{"0_0": "cancerTypes", "0_0_0": "icdOTopography", "0_0_0_0": "C00-C14 Lip, oral cavity and pharynx", "0_0_0_0_0": "C00 Lip", "0_0_0_0_0_0": "C00.0 External upper lip", "0_0_0_0_0_1": "C00.1 External lower lip", "0_0_0_0_0_2": "C00.2 External lip, nos", "0_0_0_0_0_3": "C00.3 Mucosa of upper lip", "0_0_0_0_0_4": "C00.4 Mucosa of lower lip", "0_0_0_0_0_5": "C00.5 Mucosa of lip, nos", "0_0_0_0_0_6": "C00.6 Commissure of lip", "0_0_0_0_0_7": "C00.8 Overlapping lesion of lip", "0_0_0_0_0_8": "C00.9 Lip, nos", "0_0_0_0_1": "C01 Base of tongue", "0_0_0_0_1_0": "C01.9 Base of tongue, nos", "0_0_0_0_2": "C02 Other and unspecified parts of tongue", "0_0_0_0_2_0": "C02.0 Dorsal surface of tongue, nos", "0_0_0_0_2_1": "C02.1 Border of tongue", "0_0_0_0_2_2": "C02.2 Ventral surface of tongue, nos", "0_0_0_0_2_3": "C02.3 Anterior 2/3 of tongue, nos", "0_0_0_0_2_4": "C02.4 Lingual tonsil", "0_0_0_0_2_5": "C02.8 Overlapping lesion of tongue", "0_0_0_0_2_6": "C02.9 Tongue, nos", "0_0_0_0_3": "C03 Gum", "0_0_0_0_3_0": "C03.0 Upper gum", "0_0_0_0_3_1": "C03.1 Lower gum", "0_0_0_0_3_2": "C03.9 Gum, nos", "0_0_0_0_4": "C04 Floor of mouth", "0_0_0_0_4_0": "C04.0 Anterior floor of mouth", "0_0_0_0_4_1": "C04.1 Lateral floor of mouth", "0_0_0_0_4_2": "C04.8 Overlapping lesion of floor of mouth", "0_0_0_0_4_3": "C04.9 Floor of mouth, nos", "0_0_0_0_5": "C05 Palate", "0_0_0_0_5_0": "C05.0 Hard palate", "0_0_0_0_5_1": "C05.1 Soft palate, nos", "0_0_0_0_5_2": "C05.2 Uvula", "0_0_0_0_5_3": "C05.8 Overlapping lesion of palate", "0_0_0_0_5_4": "C05.9 Palate, nos", "0_0_0_0_6": "C06 Other and unspecified parts of mouth", "0_0_0_0_6_0": "C06.0 Cheek mucosa", "0_0_0_0_6_1": "C06.1 Vestibule of mouth", "0_0_0_0_6_2": "C06.2 Retromolar area", "0_0_0_0_6_3": "C06.8 Overlapping lesion of other and unspecified parts of mouth", "0_0_0_0_6_4": "C06.9 Mouth, nos", "0_0_0_0_7": "C07 Parotid gland", "0_0_0_0_7_0": "C07.9 Parotid gland", "0_0_0_0_8": "C08 Other and unspecified major salivary glands", "0_0_0_0_8_0": "C08.0 Submandibular gland", "0_0_0_0_8_1": "C08.1 Sublingual gland", "0_0_0_0_8_2": "C08.8 Overlapping lesion of major salivary glands", "0_0_0_0_8_3": "C08.9 Major salivary gland, nos", "0_0_0_0_9": "C09 Tonsil", "0_0_0_0_9_0": "C09.0 Tonsillar fossa", "0_0_0_0_9_1": "C09.1 Tonsillar pillar", "0_0_0_0_9_2": "C09.8 Overlapping lesion of tonsil", "0_0_0_0_9_3": "C09.9 Tonsil, nos", "0_0_0_0_10": "C10 Oropharynx", "0_0_0_0_10_0": "C10.0 Vallecula", "0_0_0_0_10_1": "C10.1 Anterior surface of epiglottis", "0_0_0_0_10_2": "C10.2 Lateral wall of oropharynx", "0_0_0_0_10_3": "C10.3 Posterior wall of oropharynx", "0_0_0_0_10_4": "C10.4 Branchial cleft", "0_0_0_0_10_5": "C10.8 Overlapping lesion of oropharynx", "0_0_0_0_10_6": "C10.9 Oropharynx, nos", "0_0_0_0_11": "C11 Nasopharynx", "0_0_0_0_11_0": "C11.0 Superior wall of nasopharynx", "0_0_0_0_11_1": "C11.1 Posterior wall of nasopharynx", "0_0_0_0_11_2": "C11.2 Lateral wall of nasopharynx", "0_0_0_0_11_3": "C11.3 Anterior wall of nasopharynx", "0_0_0_0_11_4": "C11.8 Overlapping lesion of nasopharynx", "0_0_0_0_11_5": "C11.9 Nasopharynx, nos", "0_0_0_0_12": "C12 Pyriform sinus", "0_0_0_0_12_0": "C12.9 Pyriform sinus", "0_0_0_0_13": "C13 Hypopharynx", "0_0_0_0_13_0": "C13.0 Postcricoid region", "0_0_0_0_13_1": "C13.1 Hypopharyngeal aspect of aryepiglottic fold", "0_0_0_0_13_2": "C13.2 Posterior wall of hypopharynx", "0_0_0_0_13_3": "C13.8 Overlapping lesion of hypopharynx", "0_0_0_0_13_4": "C13.9 Hypopharynx, nos", "0_0_0_0_14": "C14 Other and ill-defined sites in lip, oral cavity and pharynx", "0_0_0_0_14_0": "C14.0 Pharynx, nos", "0_0_0_0_14_1": "C14.2 Waldeyer ring", "0_0_0_0_14_2": "C14.8 Overlapping lesion of lip, oral cavity and pharynx", "0_0_0_1": "C15-C26 Digestive organs", "0_0_0_1_0": "C15 Esophagus", "0_0_0_1_0_0": "C15.0 Cervical esophagus", "0_0_0_1_0_1": "C15.1 Thoracic esophagus", "0_0_0_1_0_2": "C15.2 Abdominal esophagus", "0_0_0_1_0_3": "C15.3 Upper third of esophagus", "0_0_0_1_0_4": "C15.4 Middle third of esophagus", "0_0_0_1_0_5": "C15.5 Lower third of esophagus", "0_0_0_1_0_6": "C15.8 Overlapping lesion of esophagus", "0_0_0_1_0_7": "C15.9 Esophagus, nos", "0_0_0_1_1": "C16 Stomach", "0_0_0_1_1_0": "C16.0 Cardia, nos", "0_0_0_1_1_1": "C16.1 Fundus of stomach", "0_0_0_1_1_2": "C16.2 Body of stomach", "0_0_0_1_1_3": "C16.3 Gastric antrum", "0_0_0_1_1_4": "C16.4 Pylorus", "0_0_0_1_1_5": "C16.5 Lesser curvature of stomach, nos", "0_0_0_1_1_6": "C16.6 Greater curvature of stomach, nos", "0_0_0_1_1_7": "C16.8 Overlapping lesion of stomach", "0_0_0_1_1_8": "C16.9 Stomach, nos", "0_0_0_1_2": "C17 Small intestine", "0_0_0_1_2_0": "C17.0 Duodenum", "0_0_0_1_2_1": "C17.1 Jejunum", "0_0_0_1_2_2": "C17.2 Ileum", "0_0_0_1_2_3": "C17.3 Meckel diverticulum", "0_0_0_1_2_4": "C17.8 Overlapping lesion of small intestine", "0_0_0_1_2_5": "C17.9 Small intestine, nos", "0_0_0_1_3": "C18 Colon", "0_0_0_1_3_0": "C18.0 Cecum", "0_0_0_1_3_1": "C18.1 Appendix", "0_0_0_1_3_2": "C18.2 Ascending colon", "0_0_0_1_3_3": "C18.3 Hepatic flexure of colon", "0_0_0_1_3_4": "C18.4 Transverse colon", "0_0_0_1_3_5": "C18.5 Splenic flexure of colon", "0_0_0_1_3_6": "C18.6 Descending colon", "0_0_0_1_3_7": "C18.7 Sigmoid colon", "0_0_0_1_3_8": "C18.8 Overlapping lesion of colon", "0_0_0_1_3_9": "C18.9 Colon, nos", "0_0_0_1_4": "C19 Rectosigmoid junction", "0_0_0_1_4_0": "C19.9 Rectosigmoid junction", "0_0_0_1_5": "C20 Rectum", "0_0_0_1_5_0": "C20.9 Rectum, nos", "0_0_0_1_6": "C21 Anus and anal canal", "0_0_0_1_6_0": "C21.0 Anus, nos", "0_0_0_1_6_1": "C21.1 Anal canal", "0_0_0_1_6_2": "C21.2 Cloacogenic zone", "0_0_0_1_6_3": "C21.8 Overlapping lesion of rectum, anus and anal canal", "0_0_0_1_7": "C22 Liver and intrahepatic bile ducts", "0_0_0_1_7_0": "C22.0 Liver", "0_0_0_1_7_1": "C22.1 Intrahepatic bile duct", "0_0_0_1_8": "C23 Gallbladder", "0_0_0_1_8_0": "C23.9 Gallbladder", "0_0_0_1_9": "C24 Other and unspecified parts of biliary tract", "0_0_0_1_9_0": "C24.0 Extrahepatic bile duct", "0_0_0_1_9_1": "C24.1 Ampulla of vater", "0_0_0_1_9_2": "C24.8 Overlapping lesion of biliary tract", "0_0_0_1_9_3": "C24.9 Biliary tract, nos", "0_0_0_1_10": "C25 Pancreas", "0_0_0_1_10_0": "C25.0 Head of pancreas", "0_0_0_1_10_1": "C25.1 Body of pancreas", "0_0_0_1_10_2": "C25.2 Tail of pancreas", "0_0_0_1_10_3": "C25.3 Pancreatic duct", "0_0_0_1_10_4": "C25.4 Islets of langerhans", "0_0_0_1_10_5": "C25.7 Other specified parts of pancreas", "0_0_0_1_10_6": "C25.8 Overlapping lesion of pancreas", "0_0_0_1_10_7": "C25.9 Pancreas, nos", "0_0_0_1_11": "C26 Other and ill-defined digestive organs", "0_0_0_1_11_0": "C26.0 Intestinal tract, nos", "0_0_0_1_11_1": "C26.8 Overlapping lesion of digestive system", "0_0_0_1_11_2": "C26.9 Gastrointestinal tract, nos", "0_0_0_2": "C30-C39 Respiratory system and intrathoracic organs", "0_0_0_2_0": "C30 Nasal cavity and middle ear", "0_0_0_2_0_0": "C30.0 Nasal cavity", "0_0_0_2_0_1": "C30.1 Middle ear", "0_0_0_2_1": "C31 Accessory sinuses", "0_0_0_2_1_0": "C31.0 Maxillary sinus", "0_0_0_2_1_1": "C31.1 Ethmoid sinus", "0_0_0_2_1_2": "C31.2 Frontal sinus", "0_0_0_2_1_3": "C31.3 Sphenoid sinus", "0_0_0_2_1_4": "C31.8 Overlapping lesion of accessory sinuses", "0_0_0_2_1_5": "C31.9 Accessory sinus, nos", "0_0_0_2_2": "C32 Larynx", "0_0_0_2_2_0": "C32.0 Glottis", "0_0_0_2_2_1": "C32.1 Supraglottis", "0_0_0_2_2_2": "C32.2 Subglottis", "0_0_0_2_2_3": "C32.3 Laryngeal cartilage", "0_0_0_2_2_4": "C32.8 Overlapping lesion of larynx", "0_0_0_2_2_5": "C32.9 Larynx, nos", "0_0_0_2_3": "C33 Trachea", "0_0_0_2_3_0": "C33.9 Trachea", "0_0_0_2_4": "C34 Bronchus and lung", "0_0_0_2_4_0": "C34.0 Main bronchus", "0_0_0_2_4_1": "C34.1 Upper lobe, lung", "0_0_0_2_4_2": "C34.2 Middle lobe, lung", "0_0_0_2_4_3": "C34.3 Lower lobe, lung", "0_0_0_2_4_4": "C34.8 Overlapping lesion of lung", "0_0_0_2_4_5": "C34.9 Lung, nos", "0_0_0_2_5": "C37 Thymus", "0_0_0_2_5_0": "C37.9 Thymus", "0_0_0_2_6": "C38 Heart, mediastinum, and pleura", "0_0_0_2_6_0": "C38.0 Heart", "0_0_0_2_6_1": "C38.1 Anterior mediastinum", "0_0_0_2_6_2": "C38.2 Posterior mediastinum", "0_0_0_2_6_3": "C38.3 Mediastinum, nos", "0_0_0_2_6_4": "C38.4 Pleura, nos", "0_0_0_2_6_5": "C38.8 Overlapping lesion of heart, mediastinum and pleura", "0_0_0_2_7": "C39 Other and ill-defined sites within respiratory system and intrathoracic organs", "0_0_0_2_7_0": "C39.0 Upper respiratory tract, nos", "0_0_0_2_7_1": "C39.8 Overlapping lesion of respiratory system and intrathoracic organs", "0_0_0_2_7_2": "C39.9 Ill-defined sites within respiratory system", "0_0_0_3": "C40-C41 Bones, joints and articular cartilage", "0_0_0_3_0": "C40 Bones, joints and articular cartilage of limbs", "0_0_0_3_0_0": "C40.0 Long bones of upper limb, scapula and associated joints", "0_0_0_3_0_1": "C40.1 Short bones of upper limb and associated joints", "0_0_0_3_0_2": "C40.2 Long bones of lower limb and associated joints", "0_0_0_3_0_3": "C40.3 Short bones of lower limb and associated joints", "0_0_0_3_0_4": "C40.8 Overlapping lesion of bones, joints and articular cartilage of limbs", "0_0_0_3_0_5": "C40.9 Bone of limb, nos", "0_0_0_3_1": "C41 Bones, joints and articular cartilage of other and unspecified sites", "0_0_0_3_1_0": "C41.0 Bones of skull and face and associated joints", "0_0_0_3_1_1": "C41.1 Mandible", "0_0_0_3_1_2": "C41.2 Vertebral column", "0_0_0_3_1_3": "C41.3 Rib, sternum, clavicle and associated joints", "0_0_0_3_1_4": "C41.4 Pelvic bones, sacrum, coccyx and associated joints", "0_0_0_3_1_5": "C41.8 Overlapping lesion of bones, joints and articular cartilage", "0_0_0_3_1_6": "C41.9 Bone, nos", "0_0_0_4": "C42 Hematopoietic and reticuloendothelial systems", "0_0_0_4_0": "C42.0 Blood", "0_0_0_4_1": "C42.1 Bone marrow", "0_0_0_4_2": "C42.2 Spleen", "0_0_0_4_3": "C42.3 Reticuloendothelial system, nos", "0_0_0_4_4": "C42.4 Hematopoietic system, nos", "0_0_0_5": "C44 Skin", "0_0_0_5_0": "C44.0 Skin of lip, nos", "0_0_0_5_1": "C44.1 Eyelid", "0_0_0_5_2": "C44.2 External ear", "0_0_0_5_3": "C44.3 Skin of other and unspecified parts of face", "0_0_0_5_4": "C44.4 Skin of scalp and neck", "0_0_0_5_5": "C44.5 Skin of trunk", "0_0_0_5_6": "C44.6 Skin of upper limb and shoulder", "0_0_0_5_7": "C44.7 Skin of lower limb and hip", "0_0_0_5_8": "C44.8 Overlapping lesion of skin", "0_0_0_5_9": "C44.9 Skin, nos", "0_0_0_6": "C47 Peripheral nerves and autonomic nervous system", "0_0_0_6_0": "C47.0 Peripheral nerves and autonomic nervous system of head, face, and neck", "0_0_0_6_1": "C47.1 Peripheral nerves and autonomic nervous system of upper limb and shoulder", "0_0_0_6_2": "C47.2 Peripheral nerves and autonomic nervous system of lower limband hip", "0_0_0_6_3": "C47.3 Peripheral nerves and autonomic nervous system of thorax", "0_0_0_6_4": "C47.4 Peripheral nerves and autonomic nervous system of abdomen", "0_0_0_6_5": "C47.5 Peripheral nerves and autonomic nervous system of pelvis", "0_0_0_6_6": "C47.6 Peripheral nerves and autonomic nervous system of trunk, nos", "0_0_0_6_7": "C47.8 Overlapping lesion of peripheral nerves and autonomic nervous system", "0_0_0_6_8": "C47.9 Autonomic nervous system, nos", "0_0_0_7": "C48 Retroperitoneum and peritoneum", "0_0_0_7_0": "C48.0 Retroperitoneum", "0_0_0_7_1": "C48.1 Specified parts of peritoneum", "0_0_0_7_2": "C48.2 Peritoneum, nos", "0_0_0_7_3": "C48.8 Overlapping lesion of retroperitoneum and peritoneum", "0_0_0_8": "C49 Connective, subcutaneous and other soft tissues", "0_0_0_8_0": "C49.0 Connective, subcutaneous and other soft tissues of head, face, and neck", "0_0_0_8_1": "C49.1 Connective, subcutaneous and other soft tissues of upper limb and shoulder", "0_0_0_8_2": "C49.2 Connective, subcutaneous and other soft tissues of lower limb and hip", "0_0_0_8_3": "C49.3 Connective, subcutaneous and other soft tissues of thorax", "0_0_0_8_4": "C49.4 Connective, subcutaneous and other soft tissues of abdomen", "0_0_0_8_5": "C49.5 Connective, subcutaneous and other soft tissues of pelvis", "0_0_0_8_6": "C49.6 Connective, subcutaneous and other soft tissues of trunk nos", "0_0_0_8_7": "C49.8 Overlapping lesion of connective, subcutaneous and other soft tissues", "0_0_0_8_8": "C49.9 Connective, subcutaneous and other soft tissues, nos", "0_0_0_9": "C50 Breast", "0_0_0_9_0": "C50.0 Nipple", "0_0_0_9_1": "C50.1 Central portion of breast", "0_0_0_9_2": "C50.2 Upper-inner quadrant of breast", "0_0_0_9_3": "C50.3 Lower-inner quadrant of breast", "0_0_0_9_4": "C50.4 Upper-outer quadrant of breast", "0_0_0_9_5": "C50.5 Lower-outer quadrant of breast", "0_0_0_9_6": "C50.6 Axillary tail of breast", "0_0_0_9_7": "C50.8 Overlapping lesion of breast", "0_0_0_9_8": "C50.9 Breast, nos", "0_0_0_10": "C51-C58 Female genital organs", "0_0_0_10_0": "C51 Vulva", "0_0_0_10_0_0": "C51.0 Labium majus", "0_0_0_10_0_1": "C51.1 Labium minus", "0_0_0_10_0_2": "C51.2 Clitoris", "0_0_0_10_0_3": "C51.8 Overlapping lesion of vulva", "0_0_0_10_0_4": "C51.9 Vulva, nos", "0_0_0_10_1": "C52 Vagina", "0_0_0_10_1_0": "C52.9 Vagina, nos", "0_0_0_10_2": "C53 Cervix uteri", "0_0_0_10_2_0": "C53.0 Endocervix", "0_0_0_10_2_1": "C53.1 Exocervix", "0_0_0_10_2_2": "C53.8 Overlapping lesion of cervix uteri", "0_0_0_10_2_3": "C53.9 Cervix uteri", "0_0_0_10_3": "C54 Corpus uteri", "0_0_0_10_3_0": "C54.0 Isthmus uteri", "0_0_0_10_3_1": "C54.1 Endometrium", "0_0_0_10_3_2": "C54.2 Myometrium", "0_0_0_10_3_3": "C54.3 Fundus uteri", "0_0_0_10_3_4": "C54.8 Overlapping lesion of corpus uteri", "0_0_0_10_3_5": "C54.9 Corpus uteri", "0_0_0_10_4": "C55 Uterus, nos", "0_0_0_10_4_0": "C55.9 Uterus, nos", "0_0_0_10_5": "C56 Ovary", "0_0_0_10_5_0": "C56.9 Ovary", "0_0_0_10_6": "C57 Other and unspecified female genital organs", "0_0_0_10_6_0": "C57.0 Fallopian tube", "0_0_0_10_6_1": "C57.1 Broad ligament", "0_0_0_10_6_2": "C57.2 Round ligament", "0_0_0_10_6_3": "C57.3 Parametrium", "0_0_0_10_6_4": "C57.4 Uterine adnexa", "0_0_0_10_6_5": "C57.7 Other specified parts of female genital organs", "0_0_0_10_6_6": "C57.8 Overlapping lesion of female genital organs", "0_0_0_10_6_7": "C57.9 Female genital tract, nos", "0_0_0_10_7": "C58 Placenta", "0_0_0_10_7_0": "C58.9 Placenta", "0_0_0_11": "C60-C63 Male genital organs", "0_0_0_11_0": "C60 Penis", "0_0_0_11_0_0": "C60.0 Prepuce", "0_0_0_11_0_1": "C60.1 Glans penis", "0_0_0_11_0_2": "C60.2 Body of penis", "0_0_0_11_0_3": "C60.8 Overlapping lesion of penis", "0_0_0_11_0_4": "C60.9 Penis, nos", "0_0_0_11_1": "C61 Prostate gland", "0_0_0_11_1_0": "C61.9 Prostate gland", "0_0_0_11_2": "C62 Testis", "0_0_0_11_2_0": "C62.0 Undescended testis", "0_0_0_11_2_1": "C62.1 Descended testis", "0_0_0_11_2_2": "C62.9 Testis, nos", "0_0_0_11_3": "C63 Other and unspecified male genital organs", "0_0_0_11_3_0": "C63.0 Epididymis", "0_0_0_11_3_1": "C63.1 Spermatic cord", "0_0_0_11_3_2": "C63.2 Scrotum, nos", "0_0_0_11_3_3": "C63.7 Other specified parts of male genital organs", "0_0_0_11_3_4": "C63.8 Overlapping lesion of male genital organs", "0_0_0_11_3_5": "C63.9 Male genital organs, nos", "0_0_0_12": "C64-C68 Urinary tract", "0_0_0_12_0": "C64 Kidney", "0_0_0_12_0_0": "C64.9 Kidney, nos", "0_0_0_12_1": "C65 Renal pelvis", "0_0_0_12_1_0": "C65.9 Renal pelvis", "0_0_0_12_2": "C66 Ureter", "0_0_0_12_2_0": "C66.9 Ureter", "0_0_0_12_3": "C67 Bladder", "0_0_0_12_3_0": "C67.0 Trigone of bladder", "0_0_0_12_3_1": "C67.1 Dome of bladder", "0_0_0_12_3_2": "C67.2 Lateral wall of bladder", "0_0_0_12_3_3": "C67.3 Anterior wall of bladder", "0_0_0_12_3_4": "C67.4 Posterior wall of bladder", "0_0_0_12_3_5": "C67.5 Bladder neck", "0_0_0_12_3_6": "C67.6 Ureteric orifice", "0_0_0_12_3_7": "C67.7 Urachus", "0_0_0_12_3_8": "C67.8 Overlapping lesion of bladder", "0_0_0_12_3_9": "C67.9 Bladder, nos", "0_0_0_12_4": "C68 Other and unspecified urinary organs", "0_0_0_12_4_0": "C68.0 Urethra", "0_0_0_12_4_1": "C68.1 Paraurethral gland", "0_0_0_12_4_2": "C68.8 Overlapping lesion of urinary organs", "0_0_0_12_4_3": "C68.9 Urinary system, nos", "0_0_0_13": "C69-C72 Eye, brain and other parts of central nervous system", "0_0_0_13_0": "C69 Eye and adnexa", "0_0_0_13_0_0": "C69.0 Conjunctiva", "0_0_0_13_0_1": "C69.1 Cornea, nos", "0_0_0_13_0_2": "C69.2 Retina", "0_0_0_13_0_3": "C69.3 Choroid", "0_0_0_13_0_4": "C69.4 Ciliary body", "0_0_0_13_0_5": "C69.5 Lacrimal gland", "0_0_0_13_0_6": "C69.6 Orbit, nos", "0_0_0_13_0_7": "C69.8 Overlapping lesion of eye and adnexa", "0_0_0_13_0_8": "C69.9 Eye, nos", "0_0_0_13_1": "C70 Meninges", "0_0_0_13_1_0": "C70.0 Cerebral meninges", "0_0_0_13_1_1": "C70.1 Spinal meninges", "0_0_0_13_1_2": "C70.9 Meninges, nos", "0_0_0_13_2": "C71 Brain", "0_0_0_13_2_0": "C71.0 Cerebrum", "0_0_0_13_2_1": "C71.1 Frontal lobe", "0_0_0_13_2_2": "C71.2 Temporal lobe", "0_0_0_13_2_3": "C71.3 Parietal lobe", "0_0_0_13_2_4": "C71.4 Occipital lobe", "0_0_0_13_2_5": "C71.5 Ventricle, nos", "0_0_0_13_2_6": "C71.6 Cerebellum, nos", "0_0_0_13_2_7": "C71.7 Brain stem", "0_0_0_13_2_8": "C71.8 Overlapping lesion of brain", "0_0_0_13_2_9": "C71.9 Brain, nos", "0_0_0_13_3": "C72 Spinal cord, cranial nerves, and other parts of central nervous system", "0_0_0_13_3_0": "C72.0 Spinal cord", "0_0_0_13_3_1": "C72.1 Cauda equina", "0_0_0_13_3_2": "C72.2 Olfactory nerve", "0_0_0_13_3_3": "C72.3 Optic nerve", "0_0_0_13_3_4": "C72.4 Acoustic nerve", "0_0_0_13_3_5": "C72.5 Cranial nerve, nos", "0_0_0_13_3_6": "C72.8 Overlapping lesion of brain and central nervous system", "0_0_0_13_3_7": "C72.9 Nervous system, nos", "0_0_0_14": "C73-C75 Thyroid and other endocrine glands", "0_0_0_14_0": "C73 Thyroid gland", "0_0_0_14_0_0": "C73.9 Thyroid gland", "0_0_0_14_1": "C74 Adrenal gland", "0_0_0_14_1_0": "C74.0 Cortex of adrenal gland", "0_0_0_14_1_1": "C74.1 Medulla of adrenal gland", "0_0_0_14_1_2": "C74.9 Adrenal gland, nos", "0_0_0_14_2": "C75 Other endocrine glands and related structures", "0_0_0_14_2_0": "C75.0 Parathyroid gland", "0_0_0_14_2_1": "C75.1 Pituitary gland", "0_0_0_14_2_2": "C75.2 Craniopharyngeal duct", "0_0_0_14_2_3": "C75.3 Pineal gland", "0_0_0_14_2_4": "C75.4 Carotid body", "0_0_0_14_2_5": "C75.5 Aortic body and other paraganglia", "0_0_0_14_2_6": "C75.8 Overlapping lesion of endocrine glands and related structures", "0_0_0_14_2_7": "C75.9 Endocrine gland, nos", "0_0_0_15": "C76 Other and ill-defined sites", "0_0_0_15_0": "C76.0 Head, face or neck, nos", "0_0_0_15_1": "C76.1 Thorax, nos", "0_0_0_15_2": "C76.2 Abdomen, nos", "0_0_0_15_3": "C76.3 Pelvis, nos", "0_0_0_15_4": "C76.4 Upper limb, nos", "0_0_0_15_5": "C76.5 Lower limb, nos", "0_0_0_15_6": "C76.7 Other ill-defined sites", "0_0_0_15_7": "C76.8 Overlapping lesion of ill-defined sites", "0_0_0_16": "C77 Lymph nodes", "0_0_0_16_0": "C77.0 Lymph nodes of head, face and neck", "0_0_0_16_1": "C77.1 Intrathoracic lymph nodes", "0_0_0_16_2": "C77.2 Intra-abdominal lymph nodes", "0_0_0_16_3": "C77.3 Lymph nodes of axilla or arm", "0_0_0_16_4": "C77.4 Lymph nodes of inguinal region or leg", "0_0_0_16_5": "C77.5 Pelvic lymph nodes", "0_0_0_16_6": "C77.8 Lymph nodes of multiple regions", "0_0_0_16_7": "C77.9 Lymph node, nos", "0_0_0_17": "C80 Unknown primary site", "0_0_0_17_0": "C80.9 Unknown primary site", "0_0_1": "icdOHistology", "0_0_1_0": "800 Neoplasms, NOS", "0_0_1_0_0": "8000/0 Neoplasm, benign", "0_0_1_0_1": "8000/1 Neoplasm, uncertain whether benign or malignant", "0_0_1_0_2": "8000/3 Neoplasm, malignant", "0_0_1_0_3": "8000/6 Neoplasm, metastatic", "0_0_1_0_4": "8000/9 Neoplasm, malignant, uncertain whether primary or metastatic", "0_0_1_0_5": "8001/0 Tumor cells, benign", "0_0_1_0_6": "8001/1 Tumor cells, uncertain whether benign or malignant", "0_0_1_0_7": "8001/3 Tumor cells, malignant", "0_0_1_0_8": "8002/3 Malignant tumor, small cell type", "0_0_1_0_9": "8003/3 Malignant tumor, giant cell type", "0_0_1_0_10": "8004/3 Malignant tumor, spindle cell type", "0_0_1_0_11": "8005/0 Clear cell tumor, NOS", "0_0_1_0_12": "8005/3 Malignant tumor, clear cell type", "0_0_1_1": "801-804 Epithelial neoplasms, NOS", "0_0_1_1_0": "8010/0 Epithelial tumor, benign", "0_0_1_1_1": "8010/2 Carcinoma in situ, NOS", "0_0_1_1_2": "8010/3 Carcinoma, NOS", "0_0_1_1_3": "8010/6 Carcinoma, metastatic, NOS", "0_0_1_1_4": "8010/9 Carcinomatosis", "0_0_1_1_5": "8011/0 Epithelioma, benign", "0_0_1_1_6": "8011/3 Epithelioma, malignant", "0_0_1_1_7": "8012/3 Large cell carcinoma, NOS", "0_0_1_1_8": "8013/3 Large cell neuroendocrine carcinoma", "0_0_1_1_9": "8014/3 Large cell carcinoma with rhabdoid phenotype", "0_0_1_1_10": "8015/3 Glassy cell carcinoma", "0_0_1_1_11": "8020/3 Carcinoma, undifferentiated, NOS", "0_0_1_1_12": "8021/3 Carcinoma, anaplastic, NOS", "0_0_1_1_13": "8022/3 Pleomorphic carcinoma", "0_0_1_1_14": "8023/3 Nuclear protein in testis (NUT) associated carcinoma", "0_0_1_1_15": "8030/3 Giant cell and spindle cell carcinoma", "0_0_1_1_16": "8031/3 Giant cell carcinoma", "0_0_1_1_17": "8032/3 Spindle cell carcinoma, NOS", "0_0_1_1_18": "8033/3 Pseudosarcomatous carcinoma", "0_0_1_1_19": "8034/3 Polygonal cell carcinoma", "0_0_1_1_20": "8035/3 Carcinoma with osteoclast-like giant cells", "0_0_1_1_21": "8040/0 Tumorlet, benign", "0_0_1_1_22": "8040/1 Tumorlet, NOS", "0_0_1_1_23": "8041/3 Small cell carcinoma, NOS", "0_0_1_1_24": "8043/3 Small cell carcinoma, fusiform cell", "0_0_1_1_25": "8044/3 Small cell carcinoma, intermediate cell", "0_0_1_1_26": "8045/3 Combined small cell carcinoma", "0_0_1_1_27": "8046/3 Non-small cell carcinoma", "0_0_1_2": "805-808 Squamous cell neoplasms", "0_0_1_2_0": "8050/0 Papilloma, NOS", "0_0_1_2_1": "8050/2 Papillary carcinoma in situ", "0_0_1_2_2": "8050/3 Papillary carcinoma, NOS", "0_0_1_2_3": "8051/0 Verrucous papilloma", "0_0_1_2_4": "8051/3 Verrucous carcinoma, NOS", "0_0_1_2_5": "8052/0 Squamous cell papilloma, NOS", "0_0_1_2_6": "8052/2 Papillary squamous cell carcinoma, non-invasive", "0_0_1_2_7": "8052/3 Papillary squamous cell carcinoma", "0_0_1_2_8": "8053/0 Squamous cell papilloma, inverted", "0_0_1_2_9": "8054/0 Warty dyskeratoma", "0_0_1_2_10": "8054/3 Warty carcinoma", "0_0_1_2_11": "8060/0 Squamous papillomatosis", "0_0_1_2_12": "8070/0 Actinic keratosis", "0_0_1_2_13": "8070/2 Squamous cell carcinoma in situ, NOS", "0_0_1_2_14": "8070/3 Squamous cell carcinoma, NOS", "0_0_1_2_15": "8070/6 Squamous cell carcinoma, metastatic, NOS", "0_0_1_2_16": "8071/2 Differentiated intraepithelial neoplasia", "0_0_1_2_17": "8071/3 Squamous cell carcinoma, keratinizing, NOS", "0_0_1_2_18": "8072/0 Large cell acanthoma", "0_0_1_2_19": "8072/3 Squamous cell carcinoma, large cell, nonkeratinizing, NOS", "0_0_1_2_20": "8073/3 Squamous cell carcinoma, small cell, nonkeratinizing", "0_0_1_2_21": "8074/3 Squamous cell carcinoma, spindle cell", "0_0_1_2_22": "8075/3 Squamous cell carcinoma, adenoid", "0_0_1_2_23": "8076/2 Squamous cell carcinoma in situ with questionable stromal invasion", "0_0_1_2_24": "8076/3 Squamous cell carcinoma, microinvasive", "0_0_1_2_25": "8077/0 Squamous intraepithelial neoplasia, low grade", "0_0_1_2_26": "8077/2 Squamous intraepithelial neoplasia, high grade", "0_0_1_2_27": "8078/3 Squamous cell carcinoma with horn formation", "0_0_1_2_28": "8080/2 Queyrat erythroplasia", "0_0_1_2_29": "8081/2 Bowen disease", "0_0_1_2_30": "8082/3 Lymphoepithelial carcinoma", "0_0_1_2_31": "8083/3 Basaloid squamous cell carcinoma", "0_0_1_2_32": "8084/0 Clear cell acanthoma", "0_0_1_2_33": "8084/3 Squamous cell carcinoma, clear cell type", "0_0_1_2_34": "8085/3 Squamous cell carcinoma, HPV-positive", "0_0_1_2_35": "8086/3 Squamous cell carcinoma, HPV-negative", "0_0_1_3": "809-811 Basal cell neoplasms", "0_0_1_3_0": "8090/3 Basal cell carcinoma, NOS", "0_0_1_3_1": "8091/3 Superficial basal cell carcinoma", "0_0_1_3_2": "8092/3 Infiltrating basal cell carcinoma, NOS", "0_0_1_3_3": "8093/3 Basal cell carcinoma, fibroepithelial", "0_0_1_3_4": "8094/3 Basosquamous carcinoma", "0_0_1_3_5": "8095/3 Metatypical carcinoma", "0_0_1_3_6": "8096/0 Intraepidermal epithelioma of Jadassohn", "0_0_1_3_7": "8097/3 Basal cell carcinoma, nodular", "0_0_1_3_8": "8098/3 Adenoid basal carcinoma", "0_0_1_3_9": "8100/0 Trichoepithelioma", "0_0_1_3_10": "8100/3 Trichoblastic carcinoma", "0_0_1_3_11": "8101/0 Trichofolliculoma", "0_0_1_3_12": "8102/0 Trichilemmoma", "0_0_1_3_13": "8102/3 Trichilemmocarcinoma", "0_0_1_3_14": "8103/0 Pilar tumor", "0_0_1_3_15": "8103/1 Proliferating trichilemmal cyst", "0_0_1_3_16": "8104/0 Pilar sheath acanthoma", "0_0_1_3_17": "8110/0 Pilomatricoma, NOS", "0_0_1_3_18": "8110/3 Pilomatrical carcinoma", "0_0_1_4": "812-813 Transitional cell papillomas and carcinomas", "0_0_1_4_0": "8120/0 Urothelial papilloma, NOS", "0_0_1_4_1": "8120/2 Urothelial carcinoma in situ", "0_0_1_4_2": "8120/3 Transitional cell carcinoma, NOS", "0_0_1_4_3": "8121/0 Sinonasal papilloma, exophytic", "0_0_1_4_4": "8121/1 Sinonasal papilloma, inverted", "0_0_1_4_5": "8121/3 Schneiderian carcinoma", "0_0_1_4_6": "8122/3 Urothelial carcinoma, sarcomatoid ", "0_0_1_4_7": "8123/3 Basaloid carcinoma", "0_0_1_4_8": "8130/1 Papillary urothelial neoplasm of low malignant potential", "0_0_1_4_9": "8130/2 Papillary urothelial carcinoma, non-invasive", "0_0_1_4_10": "8131/3 Urothelial carcinoma, micropapillary", "0_0_1_5": "814-838 Adenomas and adenocarcinomas", "0_0_1_5_0": "8140/0 Adenoma, NOS", "0_0_1_5_1": "8140/1 Atypical adenoma", "0_0_1_5_2": "8140/2 Adenocarcinoma in situ, NOS", "0_0_1_5_3": "8140/3 Adenocarcinoma, NOS", "0_0_1_5_4": "8140/6 Adenocarcinoma, metastatic, NOS", "0_0_1_5_5": "8142/3 Linitis plastica", "0_0_1_5_6": "8143/3 Superficial spreading adenocarcinoma", "0_0_1_5_7": "8144/0 Adenoma, intestinal type", "0_0_1_5_8": "8144/3 Adenocarcinoma, intestinal type", "0_0_1_5_9": "8145/3 Carcinoma, diffuse type", "0_0_1_5_10": "8146/0 Monomorphic adenoma", "0_0_1_5_11": "8147/0 Basal cell adenoma", "0_0_1_5_12": "8147/3 Basal cell adenocarcinoma", "0_0_1_5_13": "8148/0 Glandular intraepithelial neoplasia, low grade", "0_0_1_5_14": "8148/2 Glandular intraepithelial neoplasia, high grade", "0_0_1_5_15": "8149/0 Canalicular adenoma", "0_0_1_5_16": "8150/0 Pancreatic neuroendocrine microadenoma", "0_0_1_5_17": "8150/3 Pancreatic neuroendocrine tumor, nonfunctioning", "0_0_1_5_18": "8151/3 Insulinoma, NOS", "0_0_1_5_19": "8152/3 Glucagonoma, NOS", "0_0_1_5_20": "8153/3 Gastrinoma, NOS", "0_0_1_5_21": "8154/3 Mixed neuroendocrine non-neuroendocrine neoplasm (MiNEN)", "0_0_1_5_22": "8155/3 Vipoma, NOS", "0_0_1_5_23": "8156/3 Somatostatinoma, NOS", "0_0_1_5_24": "8158/3 ACTH-producing tumor", "0_0_1_5_25": "8160/0 Bile duct adenoma", "0_0_1_5_26": "8160/3 Cholangiocarcinoma", "0_0_1_5_27": "8161/0 Bile duct cystadenoma", "0_0_1_5_28": "8161/3 Bile duct cystadenocarcinoma", "0_0_1_5_29": "8162/3 Klatskin tumor", "0_0_1_5_30": "8163/0 Pancreatobiliary neoplasm, non-invasive", "0_0_1_5_31": "8163/2 Papillary neoplasm, pancreatobiliary type, with high grade intraepithelial neoplasia", "0_0_1_5_32": "8163/3 Pancreatobiliary type carcinoma", "0_0_1_5_33": "8170/0 Liver cell adenoma", "0_0_1_5_34": "8170/3 Hepatocellular carcinoma, NOS", "0_0_1_5_35": "8171/3 Hepatocellular carcinoma, fibrolamellar", "0_0_1_5_36": "8172/3 Hepatocellular carcinoma, scirrhous", "0_0_1_5_37": "8173/3 Hepatocellular carcinoma, spindle cell variant", "0_0_1_5_38": "8174/3 Hepatocellular carcinoma, clear cell type", "0_0_1_5_39": "8175/3 Hepatocellular carcinoma, pleomorphic type", "0_0_1_5_40": "8180/3 Combined hepatocellular carcinoma and cholangiocarcinoma", "0_0_1_5_41": "8190/0 Trabecular adenoma", "0_0_1_5_42": "8190/3 Trabecular adenocarcinoma", "0_0_1_5_43": "8191/0 Embryonal adenoma", "0_0_1_5_44": "8200/0 Eccrine dermal cylindroma", "0_0_1_5_45": "8200/3 Adenoid cystic carcinoma", "0_0_1_5_46": "8201/2 Cribriform carcinoma in situ", "0_0_1_5_47": "8201/3 Cribriform carcinoma, NOS", "0_0_1_5_48": "8202/0 Microcystic adenoma", "0_0_1_5_49": "8204/0 Lactating adenoma", "0_0_1_5_50": "8210/0 Adenomatous polyp, NOS", "0_0_1_5_51": "8210/2 Adenocarcinoma in situ in adenomatous polyp", "0_0_1_5_52": "8210/3 Adenocarcinoma in adenomatous polyp", "0_0_1_5_53": "8211/0 Tubular adenoma, NOS", "0_0_1_5_54": "8211/3 Tubular adenocarcinoma", "0_0_1_5_55": "8212/0 Flat adenoma", "0_0_1_5_56": "8213/0 Serrated adenoma, NOS", "0_0_1_5_57": "8213/3 Serrated adenocarcinoma", "0_0_1_5_58": "8214/3 Parietal cell carcinoma", "0_0_1_5_59": "8215/3 Adenocarcinoma of anal glands", "0_0_1_5_60": "8220/0 Adenomatous polyposis coli", "0_0_1_5_61": "8220/3 Adenocarcinoma in adenomatous polyposis coli", "0_0_1_5_62": "8221/0 Multiple adenomatous polyps", "0_0_1_5_63": "8221/3 Adenocarcinoma in multiple adenomatous polyps", "0_0_1_5_64": "8230/3 Solid carcinoma, NOS", "0_0_1_5_65": "8231/3 Carcinoma simplex", "0_0_1_5_66": "8240/3 Neuroendocrine tumor, NOS", "0_0_1_5_67": "8241/3 Enterochromaffin cell carcinoid", "0_0_1_5_68": "8242/3 Enterochromaffin-like cell tumor, malignant", "0_0_1_5_69": "8243/3 Goblet cell carcinoid", "0_0_1_5_70": "8244/3 Mixed adenoneuroendocrine carcinoma", "0_0_1_5_71": "8245/1 Tubular carcinoid", "0_0_1_5_72": "8246/3 Neuroendocrine carcinoma, NOS", "0_0_1_5_73": "8247/3 Merkel cell carcinoma", "0_0_1_5_74": "8249/3 Neuroendocrine tumor, grade 2", "0_0_1_5_75": "8250/0 Atypical adenomatous hyperplasia", "0_0_1_5_76": "8250/2 Adenocarcinoma in situ of the lung, non-mucinous", "0_0_1_5_77": "8250/3 Lepidic adenocarcinoma", "0_0_1_5_78": "8251/0 Alveolar adenoma", "0_0_1_5_79": "8252/3 Bronchiolo-alveolar carcinoma, non-mucinous", "0_0_1_5_80": "8253/2 Adenocarcinoma in situ of the lung, mucinous", "0_0_1_5_81": "8253/3 Adenocarcinoma of the lung, mucinous", "0_0_1_5_82": "8254/3 Adenocarcinoma of the lung, mixed mucinous and non-mucinous", "0_0_1_5_83": "8255/3 Adenocarcinoma with mixed subtypes", "0_0_1_5_84": "8256/3 Minimally invasive adenocarcinoma, non-mucinous", "0_0_1_5_85": "8257/3 Minimally invasive adenocarcinoma, mucinous", "0_0_1_5_86": "8260/0 Papillary adenoma, NOS", "0_0_1_5_87": "8260/1 Aggressive papillary tumor", "0_0_1_5_88": "8260/3 Papillary adenocarcinoma, NOS", "0_0_1_5_89": "8261/0 Villous adenoma, NOS", "0_0_1_5_90": "8261/2 Adenocarcinoma in situ in villous adenoma", "0_0_1_5_91": "8261/3 Adenocarcinoma in villous adenoma", "0_0_1_5_92": "8262/3 Villous adenocarcinoma", "0_0_1_5_93": "8263/0 Tubulovillous adenoma, NOS", "0_0_1_5_94": "8263/2 Adenocarcinoma in situ in tubulovillous adenoma", "0_0_1_5_95": "8263/3 Adenocarcinoma in tubulovillous adenoma", "0_0_1_5_96": "8265/3 Micropapillary carcinoma, NOS", "0_0_1_5_97": "8270/0 Chromophobe adenoma", "0_0_1_5_98": "8270/3 Chromophobe carcinoma", "0_0_1_5_99": "8271/0 Lactotroph adenoma", "0_0_1_5_100": "8272/0 Pituitary adenoma, NOS", "0_0_1_5_101": "8272/3 Pituitary carcinoma, NOS", "0_0_1_5_102": "8273/3 Pituitary blastoma", "0_0_1_5_103": "8290/0 Oxyphilic adenoma", "0_0_1_5_104": "8290/3 Oxyphilic adenocarcinoma", "0_0_1_5_105": "8310/0 Clear cell adenoma", "0_0_1_5_106": "8310/3 Clear cell adenocarcinoma, NOS", "0_0_1_5_107": "8311/3 Hereditary leiomyomatosis and renal cell carcinoma (HRCC)-associated renal cell carcinoma", "0_0_1_5_108": "8312/3 Renal cell carcinoma, NOS", "0_0_1_5_109": "8313/0 Clear cell adenofibroma", "0_0_1_5_110": "8313/1 Clear cell borderline tumor", "0_0_1_5_111": "8313/3 Clear cell adenocarcinofibroma", "0_0_1_5_112": "8314/3 Lipid-rich carcinoma", "0_0_1_5_113": "8315/3 Glycogen-rich carcinoma", "0_0_1_5_114": "8316/1 Multilocular cystic renal neoplasm of low malignant potential ", "0_0_1_5_115": "8316/3 Cyst-associated renal cell carcinoma", "0_0_1_5_116": "8317/3 Renal cell carcinoma, chromophobe type", "0_0_1_5_117": "8318/3 Renal cell carcinoma, sarcomatoid", "0_0_1_5_118": "8319/3 Collecting duct carcinoma", "0_0_1_5_119": "8320/3 Granular cell carcinoma", "0_0_1_5_120": "8321/0 Chief cell adenoma", "0_0_1_5_121": "8322/0 Water-clear cell adenoma", "0_0_1_5_122": "8322/3 Water-clear cell adenocarcinoma", "0_0_1_5_123": "8323/0 Mixed cell adenoma", "0_0_1_5_124": "8323/1 Clear cell papillary renal cell carcinoma", "0_0_1_5_125": "8323/3 Mixed cell adenocarcinoma", "0_0_1_5_126": "8324/0 Lipoadenoma", "0_0_1_5_127": "8325/0 Metanephric adenoma", "0_0_1_5_128": "8330/0 Follicular adenoma, NOS", "0_0_1_5_129": "8330/3 Follicular carcinoma, NOS", "0_0_1_5_130": "8331/3 Follicular adenocarcinoma, well differentiated", "0_0_1_5_131": "8332/3 Follicular adenocarcinoma, trabecular", "0_0_1_5_132": "8333/0 Microfollicular adenoma, NOS", "0_0_1_5_133": "8333/3 Fetal adenocarcinoma", "0_0_1_5_134": "8334/0 Macrofollicular adenoma", "0_0_1_5_135": "8335/1 Follicular tumor of uncertain malignant potential", "0_0_1_5_136": "8335/3 Follicular carcinoma, minimally invasive", "0_0_1_5_137": "8336/1 Hyalinizing trabecular tumor", "0_0_1_5_138": "8337/3 Poorly differentiated thyroid carcinoma", "0_0_1_5_139": "8339/3 Follicular carcinoma, encapsulated, angioinvasive", "0_0_1_5_140": "8340/3 Papillary carcinoma, follicular variant", "0_0_1_5_141": "8341/3 Papillary microcarcinoma", "0_0_1_5_142": "8342/3 Papillary carcinoma, oncocytic variant", "0_0_1_5_143": "8343/3 Papillary carcinoma, encapsulated of thyroid", "0_0_1_5_144": "8344/3 Papillary carcinoma, columnar cell", "0_0_1_5_145": "8345/3 Medullary thyroid carcinoma", "0_0_1_5_146": "8346/3 Mixed medullary-follicular carcinoma", "0_0_1_5_147": "8347/3 Mixed medullary-papillary carcinoma", "0_0_1_5_148": "8348/1 Well differentiated tumor of uncertain malignant potential", "0_0_1_5_149": "8349/1 Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)", "0_0_1_5_150": "8361/0 Juxtaglomerular tumor", "0_0_1_5_151": "8370/0 Adrenal cortical adenoma, NOS", "0_0_1_5_152": "8370/3 Adrenal cortical carcinoma", "0_0_1_5_153": "8371/0 Adrenal cortical adenoma, compact cell", "0_0_1_5_154": "8372/0 Adrenal cortical adenoma, pigmented", "0_0_1_5_155": "8373/0 Adrenal cortical adenoma, clear cell", "0_0_1_5_156": "8374/0 Adrenal cortical adenoma, glomerulosa cell", "0_0_1_5_157": "8375/0 Adrenal cortical adenoma, mixed cell", "0_0_1_5_158": "8380/0 Endometrioid adenoma, NOS", "0_0_1_5_159": "8380/1 Endometrioid adenoma, borderline malignancy", "0_0_1_5_160": "8380/2 Endometrioid intraepithelial neoplasia", "0_0_1_5_161": "8380/3 Endometrioid adenocarcinoma, NOS", "0_0_1_5_162": "8381/0 Endometrioid adenofibroma, NOS", "0_0_1_5_163": "8381/1 Endometrioid adenofibroma, borderline malignancy", "0_0_1_5_164": "8381/3 Endometrioid adenofibroma, malignant", "0_0_1_5_165": "8382/3 Endometrioid adenocarcinoma, secretory variant", "0_0_1_5_166": "8383/3 Endometrioid adenocarcinoma, ciliated cell variant", "0_0_1_5_167": "8384/3 Adenocarcinoma, endocervical type", "0_0_1_6": "839-842 Adnexal and skin appendage neoplasms", "0_0_1_6_0": "8390/0 Skin appendage adenoma", "0_0_1_6_1": "8390/3 Adnexal adenocarcinoma, NOS", "0_0_1_6_2": "8391/0 Follicular fibroma", "0_0_1_6_3": "8392/0 Syringofibroadenoma", "0_0_1_6_4": "8400/0 Sweat gland adenoma", "0_0_1_6_5": "8400/1 Sweat gland tumor, NOS", "0_0_1_6_6": "8400/3 Sweat gland adenocarcinoma", "0_0_1_6_7": "8401/0 Apocrine adenoma", "0_0_1_6_8": "8401/3 Apocrine adenocarcinoma", "0_0_1_6_9": "8402/0 Hidradenoma, NOS", "0_0_1_6_10": "8402/3 Hidradenocarcinoma", "0_0_1_6_11": "8403/0 Spiradenoma, NOS", "0_0_1_6_12": "8403/3 Malignant eccrine spiradenoma", "0_0_1_6_13": "8404/0 Hidrocystoma", "0_0_1_6_14": "8405/0 Papillary hidradenoma", "0_0_1_6_15": "8406/0 Syringocystadenoma papilliferum", "0_0_1_6_16": "8406/3 Syringocystadenocarcinoma papilliferum", "0_0_1_6_17": "8407/0 Syringoma, NOS", "0_0_1_6_18": "8407/3 Microcystic adnexal carcinoma", "0_0_1_6_19": "8408/0 Eccrine papillary adenoma", "0_0_1_6_20": "8408/3 Digital papillary adenocarcinoma", "0_0_1_6_21": "8409/0 Poroma, NOS", "0_0_1_6_22": "8409/2 Porocarcinoma in situ", "0_0_1_6_23": "8409/3 Porocarcinoma, NOS", "0_0_1_6_24": "8410/0 Sebaceoma", "0_0_1_6_25": "8410/3 Sebaceous carcinoma", "0_0_1_6_26": "8413/3 Eccrine adenocarcinoma", "0_0_1_6_27": "8420/0 Ceruminous adenoma", "0_0_1_6_28": "8420/3 Ceruminous adenocarcinoma", "0_0_1_7": "843 Mucoepidermoid neoplasms", "0_0_1_7_0": "8430/3 Mucoepidermoid carcinoma", "0_0_1_8": "844-849 Cystic, mucinous and serous neoplasms", "0_0_1_8_0": "8440/0 Cystadenoma, NOS", "0_0_1_8_1": "8441/0 Serous cystadenoma, NOS", "0_0_1_8_2": "8441/2 Serous intraepithelial carcinoma", "0_0_1_8_3": "8441/3 Serous carcinoma, NOS", "0_0_1_8_4": "8442/1 Serous borderline tumor, NOS", "0_0_1_8_5": "8443/0 Clear cell cystadenoma", "0_0_1_8_6": "8450/0 Papillary cystadenoma, NOS", "0_0_1_8_7": "8452/1 Solid pseudopapillary tumor of ovary", "0_0_1_8_8": "8452/3 Solid pseudopapillary neoplasm of the pancreas", "0_0_1_8_9": "8453/0 Intraductal Papillary mucinous adenoma", "0_0_1_8_10": "8453/2 Intraductal Papillary mucinous neoplasm with high grade dysplasia", "0_0_1_8_11": "8453/3 Intraductal Papillary mucinous neoplasm with an associated invasive carcinoma", "0_0_1_8_12": "8454/0 Cystic tumor of atrio-ventricular node", "0_0_1_8_13": "8460/2 Serous borderline tumor, micropapillary variant", "0_0_1_8_14": "8460/3 Low grade serous carcinoma", "0_0_1_8_15": "8461/0 Serous surface papilloma", "0_0_1_8_16": "8461/3 High grade serous carcinoma", "0_0_1_8_17": "8470/0 Mucinous cystadenoma, NOS", "0_0_1_8_18": "8470/2 Mucinous cystic neoplasm with high grade dysplasia", "0_0_1_8_19": "8470/3 Mucinous cystadenocarcinoma, NOS", "0_0_1_8_20": "8472/1 Mucinous cystic tumor of borderline malignancy", "0_0_1_8_21": "8474/0 Seromucinous cystadenoma", "0_0_1_8_22": "8474/1 Seromucinous borderline tumor", "0_0_1_8_23": "8474/3 Seromucinous carcinoma", "0_0_1_8_24": "8480/0 Mucinous adenoma", "0_0_1_8_25": "8480/1 Low grade appendiceal mucinous neoplasm", "0_0_1_8_26": "8480/3 Mucinous adenocarcinoma", "0_0_1_8_27": "8480/6 Pseudomyxoma peritonei", "0_0_1_8_28": "8481/3 Mucin-producing adenocarcinoma", "0_0_1_8_29": "8482/3 Mucinous carcinoma, gastric type", "0_0_1_8_30": "8490/3 Signet ring cell carcinoma", "0_0_1_8_31": "8490/6 Metastatic signet ring cell carcinoma", "0_0_1_9": "850-854 Ductal and lobular neoplasms", "0_0_1_9_0": "8500/2 Intraductal carcinoma, noninfiltrating, NOS", "0_0_1_9_1": "8500/3 Infiltrating duct carcinoma, NOS", "0_0_1_9_2": "8501/2 Comedocarcinoma, noninfiltrating", "0_0_1_9_3": "8501/3 Comedocarcinoma, NOS", "0_0_1_9_4": "8502/3 Secretory carcinoma", "0_0_1_9_5": "8503/0 Intraductal papilloma", "0_0_1_9_6": "8503/2 Noninfiltrating intraductal papillary adenocarcinoma", "0_0_1_9_7": "8503/3 Intraductal papillary adenocarcinoma with invasion", "0_0_1_9_8": "8504/0 Intracystic papillary adenoma", "0_0_1_9_9": "8504/2 Encapsulated papillary carcinoma", "0_0_1_9_10": "8504/3 Encapsulated papillary carcinoma with invasion", "0_0_1_9_11": "8505/0 Intraductal papillomatosis, NOS", "0_0_1_9_12": "8506/0 Adenoma of nipple", "0_0_1_9_13": "8507/2 Intraductal micropapillary carcinoma", "0_0_1_9_14": "8507/3 Invasive micropapillary carcinoma of breast", "0_0_1_9_15": "8509/2 Solid papillary carcinoma in situ", "0_0_1_9_16": "8509/3 Solid papillary carcinoma with invasion", "0_0_1_9_17": "8510/3 Medullary carcinoma, NOS", "0_0_1_9_18": "8513/3 Atypical medullary carcinoma", "0_0_1_9_19": "8514/3 Duct carcinoma, desmoplastic type", "0_0_1_9_20": "8519/2 Lobular carcinoma in situ, pleomorphic", "0_0_1_9_21": "8520/2 Lobular carcinoma in situ, NOS", "0_0_1_9_22": "8520/3 Lobular carcinoma, NOS", "0_0_1_9_23": "8521/3 Infiltrating ductular carcinoma", "0_0_1_9_24": "8522/2 Intraductal carcinoma and lobular carcinoma in situ", "0_0_1_9_25": "8522/3 Infiltrating duct and lobular carcinoma", "0_0_1_9_26": "8523/3 Infiltrating duct mixed with other types of carcinoma", "0_0_1_9_27": "8524/3 Infiltrating lobular mixed with other types of carcinoma", "0_0_1_9_28": "8525/3 Polymorphous adenocarcinoma", "0_0_1_9_29": "8530/3 Inflammatory carcinoma", "0_0_1_9_30": "8540/3 Paget disease, mammary", "0_0_1_9_31": "8541/3 Paget disease and infiltrating duct carcinoma of breast", "0_0_1_9_32": "8542/3 Paget disease, extramammary", "0_0_1_9_33": "8543/3 Paget disease and intraductal carcinoma of breast", "0_0_1_10": "855 Acinar cell neoplasms", "0_0_1_10_0": "8550/0 Acinar cell adenoma", "0_0_1_10_1": "8550/3 Acinar cell carcinoma", "0_0_1_10_2": "8552/3 Mixed acinar-ductal carcinoma", "0_0_1_11": "856-857 Complex epithelial neoplasms", "0_0_1_11_0": "8560/0 Mixed squamous cell and glandular papilloma", "0_0_1_11_1": "8560/3 Adenosquamous carcinoma", "0_0_1_11_2": "8561/0 Adenolymphoma", "0_0_1_11_3": "8562/3 Epithelial-myoepithelial carcinoma", "0_0_1_11_4": "8563/0 Lymphadenoma", "0_0_1_11_5": "8570/3 Adenocarcinoma with squamous metaplasia", "0_0_1_11_6": "8571/3 Adenocarcinoma with cartilaginous and osseous metaplasia", "0_0_1_11_7": "8572/3 Adenocarcinoma with spindle cell metaplasia", "0_0_1_11_8": "8573/3 Adenocarcinoma with apocrine metaplasia", "0_0_1_11_9": "8574/3 Adenocarcinoma with neuroendocrine differentiation", "0_0_1_11_10": "8575/3 Metaplastic carcinoma, NOS", "0_0_1_11_11": "8576/3 Hepatoid adenocarcinoma", "0_0_1_12": "858 Thymic epithelial neoplasms", "0_0_1_12_0": "8580/0 Microscopic thymoma", "0_0_1_12_1": "8580/1 Micronodular thymoma with lymphoid stroma", "0_0_1_12_2": "8580/3 Thymoma, NOS", "0_0_1_12_3": "8581/3 Thymoma, type A", "0_0_1_12_4": "8582/3 Thymoma, type AB", "0_0_1_12_5": "8583/3 Thymoma, type B1", "0_0_1_12_6": "8584/3 Thymoma, type B2", "0_0_1_12_7": "8585/3 Thymoma, type B3", "0_0_1_12_8": "8586/3 Thymic carcinoma, NOS", "0_0_1_12_9": "8587/0 Ectopic hamartomatous thymoma", "0_0_1_12_10": "8588/3 Spindle epithelial tumor with thymus-like element", "0_0_1_12_11": "8589/3 Intrathyroid thymic carcinoma", "0_0_1_13": "859-867 Specialized gonadal neoplasms", "0_0_1_13_0": "8590/0 Sex cord-stromal tumor, benign", "0_0_1_13_1": "8590/1 Sex cord-gonadal stromal tumor, NOS", "0_0_1_13_2": "8591/1 Sex cord-gonadal stromal tumor, incompletely differentiated", "0_0_1_13_3": "8592/1 Sex cord-gonadal stromal tumor, mixed forms", "0_0_1_13_4": "8593/1 Stromal tumor with minor sex cord elements", "0_0_1_13_5": "8594/1 Mixed germ cell-sex cord-stromal tumor, NOS", "0_0_1_13_6": "8600/0 Thecoma, NOS", "0_0_1_13_7": "8600/3 Thecoma, malignant", "0_0_1_13_8": "8601/0 Thecoma, luteinized", "0_0_1_13_9": "8602/0 Sclerosing stromal tumor", "0_0_1_13_10": "8610/0 Luteoma, NOS", "0_0_1_13_11": "8620/1 Adult granulosa cell tumor of testis", "0_0_1_13_12": "8620/3 Adult granulosa cell tumor of ovary", "0_0_1_13_13": "8621/1 Granulosa cell-theca cell tumor", "0_0_1_13_14": "8622/0 Granulosa cell tumor of the testis, juvenile", "0_0_1_13_15": "8622/1 Granulosa cell tumor, juvenile", "0_0_1_13_16": "8623/1 Sex cord tumor with annular tubules", "0_0_1_13_17": "8631/0 Sertoli-Leydig cell tumor, well differentiated", "0_0_1_13_18": "8631/1 Sertoli-Leydig cell tumor of intermediate differentiation", "0_0_1_13_19": "8631/3 Sertoli-Leydig cell tumor, poorly differentiated", "0_0_1_13_20": "8632/1 Gynandroblastoma", "0_0_1_13_21": "8633/1 Sertoli-Leydig cell tumor, retiform", "0_0_1_13_22": "8634/1 Sertoli-Leydig cell tumor, intermediate differentiation, with heterologous elements", "0_0_1_13_23": "8634/3 Sertoli-Leydig cell tumor, poorly differentiated, with heterologous elements", "0_0_1_13_24": "8640/1 Sertoli cell tumor, NOS", "0_0_1_13_25": "8640/3 Sertoli cell carcinoma", "0_0_1_13_26": "8641/0 Sertoli cell tumor with lipid storage", "0_0_1_13_27": "8642/1 Large cell calcifying Sertoli cell tumor", "0_0_1_13_28": "8643/1 Intratubular large cell hyalinizing Sertoli cell neoplasia", "0_0_1_13_29": "8650/0 Leydig cell tumor of the ovary, NOS", "0_0_1_13_30": "8650/1 Leydig cell tumor of the testis, NOS", "0_0_1_13_31": "8650/3 Leydig cell tumor, malignant", "0_0_1_13_32": "8660/0 Hilus cell tumor", "0_0_1_13_33": "8670/0 Lipid cell tumor of ovary", "0_0_1_13_34": "8670/3 Steroid cell tumor, malignant", "0_0_1_13_35": "8671/0 Adrenal rest tumor", "0_0_1_14": "868-871 Paragangliomas and glomus tumors", "0_0_1_14_0": "8680/3 Paraganglioma, NOS", "0_0_1_14_1": "8681/3 Sympathetic paraganglioma", "0_0_1_14_2": "8682/3 Parasympathetic paraganglioma", "0_0_1_14_3": "8683/0 Gangliocytic paraganglioma", "0_0_1_14_4": "8690/3 Middle ear paraganglioma", "0_0_1_14_5": "8691/3 Aortic body tumor", "0_0_1_14_6": "8692/3 Carotid body paraganglioma", "0_0_1_14_7": "8693/3 Extra-adrenal paraganglioma, NOS", "0_0_1_14_8": "8700/3 Pheochromocytoma, NOS", "0_0_1_14_9": "8710/3 Glomangiosarcoma", "0_0_1_14_10": "8711/0 Glomus tumor, NOS", "0_0_1_14_11": "8711/1 Glomangiomatosis", "0_0_1_14_12": "8711/3 Glomus tumor, malignant", "0_0_1_14_13": "8712/0 Glomangioma", "0_0_1_14_14": "8713/0 Glomangiomyoma", "0_0_1_14_15": "8714/0 Perivascular epithelioid tumor, benign", "0_0_1_14_16": "8714/3 Perivascular epithelioid tumor, malignant", "0_0_1_15": "872-879 Nevi and melanomas", "0_0_1_15_0": "8720/0 Pigmented nevus, NOS", "0_0_1_15_1": "8720/2 Melanoma in situ", "0_0_1_15_2": "8720/3 Malignant melanoma, NOS", "0_0_1_15_3": "8721/3 Nodular melanoma", "0_0_1_15_4": "8722/0 Balloon cell nevus", "0_0_1_15_5": "8722/3 Balloon cell melanoma", "0_0_1_15_6": "8723/0 Halo nevus", "0_0_1_15_7": "8723/3 Malignant melanoma, regressing", "0_0_1_15_8": "8725/0 Neuronevus", "0_0_1_15_9": "8726/0 Magnocellular nevus", "0_0_1_15_10": "8727/0 Dysplastic nevus", "0_0_1_15_11": "8728/0 Meningeal melanocytosis", "0_0_1_15_12": "8728/1 Meningeal melanocytoma", "0_0_1_15_13": "8728/3 Meningeal melanomatosis", "0_0_1_15_14": "8730/0 Nonpigmented nevus", "0_0_1_15_15": "8730/3 Amelanotic melanoma", "0_0_1_15_16": "8740/0 Junctional nevus, NOS", "0_0_1_15_17": "8740/3 Malignant melanoma in junctional nevus", "0_0_1_15_18": "8741/2 Precancerous melanosis, NOS", "0_0_1_15_19": "8741/3 Malignant melanoma in precancerous melanosis", "0_0_1_15_20": "8742/0 Lentiginous melanocytic nevus", "0_0_1_15_21": "8742/2 Lentigo maligna", "0_0_1_15_22": "8742/3 Lentigo maligna melanoma", "0_0_1_15_23": "8743/3 Low cumulative sun damage melanoma", "0_0_1_15_24": "8744/0 Acral nevus", "0_0_1_15_25": "8744/3 Acral melanoma", "0_0_1_15_26": "8745/3 Desmoplastic melanoma", "0_0_1_15_27": "8746/3 Mucosal lentiginous melanoma", "0_0_1_15_28": "8750/0 Dermal nevus", "0_0_1_15_29": "8760/0 Compound nevus", "0_0_1_15_30": "8761/0 Congenital melanocytic nevus, NOS", "0_0_1_15_31": "8761/1 Giant pigmented nevus, NOS", "0_0_1_15_32": "8761/3 Malignant melanoma arising in giant congenital nevus", "0_0_1_15_33": "8762/1 Proliferative dermal lesion in congenital nevus", "0_0_1_15_34": "8770/0 Epithelioid and spindle cell nevus", "0_0_1_15_35": "8770/3 Malignant Spitz tumor", "0_0_1_15_36": "8771/0 Epithelioid cell nevus", "0_0_1_15_37": "8771/3 Epithelioid cell melanoma", "0_0_1_15_38": "8772/0 Spindle cell nevus, NOS", "0_0_1_15_39": "8772/3 Spindle cell melanoma, NOS", "0_0_1_15_40": "8773/3 Spindle cell melanoma, type A", "0_0_1_15_41": "8774/3 Spindle cell melanoma, type B", "0_0_1_15_42": "8780/0 Blue nevus, NOS", "0_0_1_15_43": "8780/1 Pigmented epithelioid melanocytoma", "0_0_1_15_44": "8790/0 Cellular blue nevus", "0_0_1_16": "880 Soft tissue tumors and sarcomas, NOS", "0_0_1_16_0": "8800/0 Soft tissue tumor, benign", "0_0_1_16_1": "8800/3 Sarcoma, NOS", "0_0_1_16_2": "8800/9 Sarcomatosis, NOS", "0_0_1_16_3": "8801/3 Spindle cell sarcoma", "0_0_1_16_4": "8802/1 Pleomorphic hyalinizing angiectatic tumor", "0_0_1_16_5": "8802/3 Giant cell sarcoma", "0_0_1_16_6": "8803/3 Small cell sarcoma", "0_0_1_16_7": "8804/3 Epithelioid sarcoma", "0_0_1_16_8": "8805/3 Undifferentiated sarcoma", "0_0_1_16_9": "8806/3 Desmoplastic small round cell tumor", "0_0_1_17": "881-883 Fibromatous neoplasms", "0_0_1_17_0": "8810/0 Fibroma, NOS", "0_0_1_17_1": "8810/1 Cellular fibroma", "0_0_1_17_2": "8810/3 Fibrosarcoma, NOS", "0_0_1_17_3": "8811/0 Fibromyxoma, NOS", "0_0_1_17_4": "8811/1 Myxoinflammatory fibroblastic sarcoma", "0_0_1_17_5": "8811/3 Myxofibrosarcoma", "0_0_1_17_6": "8812/0 Periosteal fibroma", "0_0_1_17_7": "8812/3 Periosteal fibrosarcoma", "0_0_1_17_8": "8813/0 Fibroma of tendon sheath", "0_0_1_17_9": "8813/1 Palmar/plantar type fibromatosis", "0_0_1_17_10": "8813/3 Fascial fibrosarcoma", "0_0_1_17_11": "8814/3 Infantile fibrosarcoma", "0_0_1_17_12": "8815/0 Solitary fibrous tumor/Hemangiopericytoma, grade 1", "0_0_1_17_13": "8815/1 Solitary fibrous tumor, NOS", "0_0_1_17_14": "8815/3 Solitary fibrous tumor, malignant", "0_0_1_17_15": "8816/0 Calcifying aponeurotic fibroma", "0_0_1_17_16": "8817/0 Calcifying fibrous tumor", "0_0_1_17_17": "8818/0 Fibrous dysplasia", "0_0_1_17_18": "8820/0 Elastofibroma", "0_0_1_17_19": "8821/1 Aggressive fibromatosis", "0_0_1_17_20": "8822/1 Abdominal fibromatosis", "0_0_1_17_21": "8823/0 Sclerotic fibroma", "0_0_1_17_22": "8823/1 Desmoplastic fibroma", "0_0_1_17_23": "8824/0 Myofibroma", "0_0_1_17_24": "8824/1 Myofibromatosis", "0_0_1_17_25": "8825/0 Myofibroblastoma", "0_0_1_17_26": "8825/1 Myofibroblastic tumor, NOS", "0_0_1_17_27": "8825/3 Myofibroblastic sarcoma", "0_0_1_17_28": "8826/0 Angiomyofibroblastoma", "0_0_1_17_29": "8827/1 Myofibroblastic tumor, peribronchial", "0_0_1_17_30": "8828/0 Nodular fasciitis", "0_0_1_17_31": "8830/0 Benign fibrous histiocytoma, NOS", "0_0_1_17_32": "8830/1 Atypical fibrous histiocytoma", "0_0_1_17_33": "8830/3 Malignant fibrous histiocytoma", "0_0_1_17_34": "8831/0 Histiocytoma, NOS", "0_0_1_17_35": "8832/0 Dermatofibroma, NOS", "0_0_1_17_36": "8832/1 Dermatofibrosarcoma protuberans, NOS", "0_0_1_17_37": "8832/3 Dermatofibrosarcoma protuberans, fibrosarcomatous", "0_0_1_17_38": "8833/1 Pigmented dermatofibrosarcoma protuberans", "0_0_1_17_39": "8834/1 Giant cell fibroblastoma", "0_0_1_17_40": "8835/1 Plexiform fibrohistiocytic tumor", "0_0_1_17_41": "8836/1 Angiomatoid fibrous histiocytoma", "0_0_1_18": "884 Myxomatous neoplasms", "0_0_1_18_0": "8840/0 Myxoma, NOS", "0_0_1_18_1": "8840/3 Myxosarcoma", "0_0_1_18_2": "8841/0 Angiomyxoma, NOS", "0_0_1_18_3": "8842/0 Ossifying fibromyxoid tumor, NOS", "0_0_1_18_4": "8842/3 Ossifying fibromyxoid tumor, malignant", "0_0_1_19": "885-888 Lipomatous neoplasms", "0_0_1_19_0": "8850/0 Lipoma, NOS", "0_0_1_19_1": "8850/1 Atypical lipomatous tumor", "0_0_1_19_2": "8850/3 Liposarcoma, NOS", "0_0_1_19_3": "8851/0 Fibrolipoma", "0_0_1_19_4": "8851/1 Lipofibromatosis", "0_0_1_19_5": "8851/3 Liposarcoma, well differentiated, NOS", "0_0_1_19_6": "8852/0 Fibromyxolipoma", "0_0_1_19_7": "8852/3 Myxoid liposarcoma", "0_0_1_19_8": "8854/3 Pleomorphic liposarcoma", "0_0_1_19_9": "8855/3 Mixed liposarcoma", "0_0_1_19_10": "8856/0 Intramuscular lipoma", "0_0_1_19_11": "8857/0 Spindle cell lipoma", "0_0_1_19_12": "8857/3 Fibroblastic liposarcoma", "0_0_1_19_13": "8858/3 Dedifferentiated liposarcoma", "0_0_1_19_14": "8860/0 Angiomyolipoma", "0_0_1_19_15": "8860/1 Angiomyolipoma, epithelioid", "0_0_1_19_16": "8861/0 Angiolipoma, NOS", "0_0_1_19_17": "8862/0 Chondroid lipoma", "0_0_1_19_18": "8870/0 Myelolipoma", "0_0_1_19_19": "8880/0 Hibernoma", "0_0_1_19_20": "8881/0 Lipoblastomatosis", "0_0_1_20": "889-892 Myomatous neoplasms", "0_0_1_20_0": "8890/0 Leiomyoma, NOS", "0_0_1_20_1": "8890/1 Leiomyomatosis, NOS", "0_0_1_20_2": "8890/3 Leiomyosarcoma, NOS", "0_0_1_20_3": "8891/0 Epithelioid leiomyoma", "0_0_1_20_4": "8891/3 Epithelioid leiomyosarcoma", "0_0_1_20_5": "8892/0 Cellular leiomyoma", "0_0_1_20_6": "8893/0 Bizarre leiomyoma", "0_0_1_20_7": "8894/0 Angioleiomyoma", "0_0_1_20_8": "8894/3 Angiomyosarcoma", "0_0_1_20_9": "8895/0 Myoma", "0_0_1_20_10": "8895/3 Myosarcoma", "0_0_1_20_11": "8896/0 Myxoid leiomyoma", "0_0_1_20_12": "8896/3 Myxoid leiomyosarcoma", "0_0_1_20_13": "8897/1 Smooth muscle tumor of uncertain malignant potential", "0_0_1_20_14": "8898/1 Metastasizing leiomyoma", "0_0_1_20_15": "8900/0 Rhabdomyoma, NOS", "0_0_1_20_16": "8900/3 Rhabdomyosarcoma, NOS", "0_0_1_20_17": "8901/3 Pleomorphic rhabdomyosarcoma, adult type", "0_0_1_20_18": "8902/3 Mixed type rhabdomyosarcoma", "0_0_1_20_19": "8903/0 Fetal rhabdomyoma", "0_0_1_20_20": "8904/0 Adult cellular rhabdomyoma", "0_0_1_20_21": "8905/0 Genital rhabdomyoma", "0_0_1_20_22": "8910/3 Embryonal rhabdomyosarcoma, NOS", "0_0_1_20_23": "8912/3 Spindle cell rhabdomyosarcoma", "0_0_1_20_24": "8920/3 Alveolar rhabdomyosarcoma", "0_0_1_20_25": "8921/3 Ectomesenchymoma", "0_0_1_21": "893-899 Complex mixed and stromal neoplasms", "0_0_1_21_0": "8930/0 Endometrial stromal nodule", "0_0_1_21_1": "8930/3 Endometrial stromal sarcoma, NOS", "0_0_1_21_2": "8931/3 Endometrial stromal sarcoma, low grade", "0_0_1_21_3": "8932/0 Adenomyoma, NOS", "0_0_1_21_4": "8933/3 Adenosarcoma", "0_0_1_21_5": "8934/3 Carcinofibroma", "0_0_1_21_6": "8935/0 Stromal tumor, benign", "0_0_1_21_7": "8935/1 Stromal tumor, NOS", "0_0_1_21_8": "8935/3 Stromal sarcoma, NOS", "0_0_1_21_9": "8936/3 Gastrointestinal stromal tumor", "0_0_1_21_10": "8940/0 Pleomorphic adenoma", "0_0_1_21_11": "8940/3 Mixed tumor, malignant, NOS", "0_0_1_21_12": "8941/3 Carcinoma ex pleomorphic adenoma", "0_0_1_21_13": "8950/3 Mullerian mixed tumor", "0_0_1_21_14": "8951/3 Mesodermal mixed tumor", "0_0_1_21_15": "8959/0 Benign cystic nephroma", "0_0_1_21_16": "8959/1 Cystic partially differentiated nephroblastoma", "0_0_1_21_17": "8959/3 Malignant cystic nephroma", "0_0_1_21_18": "8960/1 Mesoblastic nephroma", "0_0_1_21_19": "8960/3 Nephroblastoma, NOS", "0_0_1_21_20": "8963/3 Rhabdoid tumor, NOS", "0_0_1_21_21": "8964/3 Clear cell sarcoma of kidney", "0_0_1_21_22": "8966/0 Renomedullary interstitial cell tumor", "0_0_1_21_23": "8967/0 Ossifying renal tumor", "0_0_1_21_24": "8970/3 Hepatoblastoma, NOS", "0_0_1_21_25": "8971/3 Pancreatoblastoma", "0_0_1_21_26": "8972/3 Pulmonary blastoma", "0_0_1_21_27": "8973/3 Pleuropulmonary blastoma", "0_0_1_21_28": "8974/1 Sialoblastoma", "0_0_1_21_29": "8975/1 Calcifying nested stromal-epithelial tumor", "0_0_1_21_30": "8980/3 Carcinosarcoma, NOS", "0_0_1_21_31": "8981/3 Carcinosarcoma, embryonal", "0_0_1_21_32": "8982/0 Myoepithelioma, NOS", "0_0_1_21_33": "8982/3 Myoepithelial carcinoma", "0_0_1_21_34": "8983/0 Adenomyoepithelioma, NOS", "0_0_1_21_35": "8983/3 Adenomyoepithelioma with carcinoma", "0_0_1_21_36": "8990/0 Mesenchymoma, benign", "0_0_1_21_37": "8990/1 Mesenchymoma, NOS", "0_0_1_21_38": "8990/3 Mesenchymoma, malignant", "0_0_1_21_39": "8991/3 Embryonal sarcoma", "0_0_1_21_40": "8992/0 Pulmonary hamartoma", "0_0_1_22": "900-903 Fibroepithelial neoplasms", "0_0_1_22_0": "9000/0 Brenner tumor, NOS", "0_0_1_22_1": "9000/1 Brenner tumor, borderline malignancy", "0_0_1_22_2": "9000/3 Brenner tumor, malignant", "0_0_1_22_3": "9010/0 Fibroadenoma, NOS", "0_0_1_22_4": "9011/0 Intracanalicular fibroadenoma", "0_0_1_22_5": "9012/0 Pericanalicular fibroadenoma", "0_0_1_22_6": "9013/0 Adenofibroma, NOS", "0_0_1_22_7": "9014/0 Serous adenofibroma, NOS", "0_0_1_22_8": "9014/1 Serous adenofibroma of borderline malignancy", "0_0_1_22_9": "9014/3 Serous adenocarcinofibroma", "0_0_1_22_10": "9015/0 Mucinous adenofibroma, NOS", "0_0_1_22_11": "9015/1 Mucinous adenofibroma of borderline malignancy", "0_0_1_22_12": "9015/3 Mucinous adenocarcinofibroma", "0_0_1_22_13": "9016/0 Giant fibroadenoma", "0_0_1_22_14": "9020/0 Phyllodes tumor, benign", "0_0_1_22_15": "9020/1 Phyllodes tumor, borderline", "0_0_1_22_16": "9020/3 Phyllodes tumor, malignant", "0_0_1_22_17": "9030/0 Juvenile fibroadenoma", "0_0_1_23": "904 Synovial-like neoplasms", "0_0_1_23_0": "9040/0 Synovioma, benign", "0_0_1_23_1": "9040/3 Synovial sarcoma, NOS", "0_0_1_23_2": "9041/3 Synovial sarcoma, spindle cell", "0_0_1_23_3": "9042/3 Synovial sarcoma, epithelioid cell", "0_0_1_23_4": "9043/3 Synovial sarcoma, biphasic", "0_0_1_23_5": "9044/3 Clear cell sarcoma, NOS", "0_0_1_23_6": "9045/3 Biphenotypic sinonasal sarcoma", "0_0_1_24": "905 Mesothelial neoplasms", "0_0_1_24_0": "9050/0 Mesothelioma, benign", "0_0_1_24_1": "9050/3 Mesothelioma, malignant", "0_0_1_24_2": "9051/0 Fibrous mesothelioma, benign", "0_0_1_24_3": "9051/3 Fibrous mesothelioma, malignant", "0_0_1_24_4": "9052/0 Epithelioid mesothelioma, benign", "0_0_1_24_5": "9052/1 Well differentiated papillary mesothelioma of the pleura", "0_0_1_24_6": "9052/3 Epithelioid mesothelioma, malignant", "0_0_1_24_7": "9053/3 Mesothelioma, biphasic, malignant", "0_0_1_24_8": "9054/0 Adenomatoid tumor, NOS", "0_0_1_24_9": "9055/0 Peritoneal inclusion cysts", "0_0_1_25": "906-909 Germ cell neoplasms", "0_0_1_25_0": "9060/3 Dysgerminoma", "0_0_1_25_1": "9061/3 Seminoma, NOS", "0_0_1_25_2": "9062/3 Seminoma, anaplastic", "0_0_1_25_3": "9063/3 Spermatocytic seminoma", "0_0_1_25_4": "9064/2 Intratubular malignant germ cells", "0_0_1_25_5": "9064/3 Germinoma", "0_0_1_25_6": "9065/3 Germ cell tumor, nonseminomatous", "0_0_1_25_7": "9070/3 Embryonal carcinoma, NOS", "0_0_1_25_8": "9071/3 Yolk sac tumor, NOS", "0_0_1_25_9": "9072/3 Polyembryoma", "0_0_1_25_10": "9073/1 Gonadoblastoma", "0_0_1_25_11": "9080/0 Teratoma, benign", "0_0_1_25_12": "9080/1 Teratoma, NOS", "0_0_1_25_13": "9080/3 Teratoma, malignant, NOS", "0_0_1_25_14": "9081/3 Teratocarcinoma", "0_0_1_25_15": "9082/3 Malignant teratoma, undifferentiated", "0_0_1_25_16": "9083/3 Malignant teratoma, intermediate", "0_0_1_25_17": "9084/0 Dermoid cyst, NOS", "0_0_1_25_18": "9084/3 Teratoma with malignant transformation", "0_0_1_25_19": "9085/3 Mixed germ cell tumor", "0_0_1_25_20": "9086/3 Germ cell tumor with associated hematological malignancy", "0_0_1_25_21": "9090/0 Struma ovarii, NOS", "0_0_1_25_22": "9090/3 Struma ovarii, malignant", "0_0_1_25_23": "9091/1 Strumal carcinoid", "0_0_1_26": "910 Trophoblastic neoplasms", "0_0_1_26_0": "9100/0 Hydatidiform mole, NOS", "0_0_1_26_1": "9100/1 Invasive hydatidiform mole", "0_0_1_26_2": "9100/3 Choriocarcinoma, NOS", "0_0_1_26_3": "9101/3 Choriocarcinoma combined with other germ cell elements", "0_0_1_26_4": "9102/3 Malignant teratoma, trophoblastic", "0_0_1_26_5": "9103/0 Partial hydatidiform mole", "0_0_1_26_6": "9104/1 Placental site trophoblastic tumor", "0_0_1_26_7": "9105/3 Trophoblastic tumor, epithelioid", "0_0_1_27": "911 Mesonephromas", "0_0_1_27_0": "9110/0 Adenoma of rete ovarii", "0_0_1_27_1": "9110/1 Wolffian tumor", "0_0_1_27_2": "9110/3 Mesonephroma, malignant", "0_0_1_28": "912-916 Blood vessel tumors", "0_0_1_28_0": "9120/0 Hemangioma, NOS", "0_0_1_28_1": "9120/3 Hemangiosarcoma", "0_0_1_28_2": "9121/0 Cavernous hemangioma", "0_0_1_28_3": "9122/0 Venous hemangioma", "0_0_1_28_4": "9123/0 Racemose hemangioma", "0_0_1_28_5": "9124/3 Kupffer cell sarcoma", "0_0_1_28_6": "9125/0 Epithelioid hemangioma", "0_0_1_28_7": "9126/0 Atypical vascular lesion", "0_0_1_28_8": "9130/1 Hemangioendothelioma, NOS", "0_0_1_28_9": "9130/3 Hemangioendothelioma, malignant", "0_0_1_28_10": "9131/0 Capillary hemangioma", "0_0_1_28_11": "9132/0 Intramuscular hemangioma", "0_0_1_28_12": "9133/3 Epithelioid hemangioendothelioma, NOS", "0_0_1_28_13": "9135/1 Papillary intralymphatic angioendothelioma", "0_0_1_28_14": "9136/1 Spindle cell hemangioendothelioma", "0_0_1_28_15": "9137/0 Myointimoma", "0_0_1_28_16": "9137/3 Intimal sarcoma", "0_0_1_28_17": "9138/1 Pseudomyogenic (epithelioid sarcoma-like) hemangioendothelioma", "0_0_1_28_18": "9140/3 Kaposi sarcoma", "0_0_1_28_19": "9141/0 Angiokeratoma", "0_0_1_28_20": "9142/0 Verrucous keratotic hemangioma", "0_0_1_28_21": "9160/0 Angiofibroma, NOS", "0_0_1_28_22": "9161/0 Acquired tufted hemangioma", "0_0_1_28_23": "9161/1 Hemangioblastoma", "0_0_1_29": "917 Lymphatic vessel tumors", "0_0_1_29_0": "9170/0 Lymphangioma, NOS", "0_0_1_29_1": "9170/3 Lymphangiosarcoma", "0_0_1_29_2": "9171/0 Capillary lymphangioma", "0_0_1_29_3": "9172/0 Cavernous lymphangioma", "0_0_1_29_4": "9173/0 Cystic lymphangioma", "0_0_1_29_5": "9174/0 Lymphangiomyoma", "0_0_1_29_6": "9174/1 Lymphangioleiomyomatosis", "0_0_1_29_7": "9175/0 Hemolymphangioma", "0_0_1_30": "918-924 Osseous and chondromatous neoplasms", "0_0_1_30_0": "9180/0 Osteoma, NOS", "0_0_1_30_1": "9180/3 Osteosarcoma, NOS", "0_0_1_30_2": "9181/3 Chondroblastic osteosarcoma", "0_0_1_30_3": "9182/3 Fibroblastic osteosarcoma", "0_0_1_30_4": "9183/3 Telangiectatic osteosarcoma", "0_0_1_30_5": "9184/3 Osteosarcoma in Paget disease of bone", "0_0_1_30_6": "9185/3 Small cell osteosarcoma", "0_0_1_30_7": "9186/3 Central osteosarcoma, NOS", "0_0_1_30_8": "9187/3 Low grade central osteosarcoma", "0_0_1_30_9": "9191/0 Osteoid osteoma, NOS", "0_0_1_30_10": "9192/3 Parosteal osteosarcoma", "0_0_1_30_11": "9193/3 Periosteal osteosarcoma", "0_0_1_30_12": "9194/3 High grade surface osteosarcoma", "0_0_1_30_13": "9195/3 Intracortical osteosarcoma", "0_0_1_30_14": "9200/0 Osteoblastoma, NOS", "0_0_1_30_15": "9200/1 Aggressive osteoblastoma", "0_0_1_30_16": "9210/0 Osteochondroma", "0_0_1_30_17": "9210/1 Osteochondromatosis, NOS", "0_0_1_30_18": "9211/0 Osteochondromyxoma", "0_0_1_30_19": "9212/0 Bizarre parosteal osteochondromatous proliferation", "0_0_1_30_20": "9213/0 Subungual exostosis", "0_0_1_30_21": "9220/0 Chondroma, NOS", "0_0_1_30_22": "9220/1 Chondromatosis, NOS", "0_0_1_30_23": "9220/3 Chondrosarcoma, NOS", "0_0_1_30_24": "9221/0 Periosteal chondroma", "0_0_1_30_25": "9221/3 Periosteal chondrosarcoma", "0_0_1_30_26": "9222/1 Atypical cartilaginous tumor", "0_0_1_30_27": "9230/1 Chondroblastoma, NOS", "0_0_1_30_28": "9230/3 Chondroblastoma, malignant", "0_0_1_30_29": "9231/3 Myxoid chondrosarcoma", "0_0_1_30_30": "9240/3 Mesenchymal chondrosarcoma", "0_0_1_30_31": "9241/0 Chondromyxoid fibroma", "0_0_1_30_32": "9242/3 Clear cell chondrosarcoma", "0_0_1_30_33": "9243/3 Dedifferentiated chondrosarcoma", "0_0_1_31": "925 Giant cell tumors", "0_0_1_31_0": "9250/1 Giant cell tumor of bone, NOS", "0_0_1_31_1": "9250/3 Giant cell tumor of bone, malignant", "0_0_1_31_2": "9251/1 Giant cell tumor of soft parts, NOS", "0_0_1_31_3": "9251/3 Malignant giant cell tumor of soft parts", "0_0_1_31_4": "9252/0 Tenosynovial giant cell tumor, NOS", "0_0_1_31_5": "9252/1 Tenosynovial giant cell tumor, diffuse", "0_0_1_31_6": "9252/3 Malignant tenosynovial giant cell tumor", "0_0_1_32": "926 Miscellaneous bone tumors", "0_0_1_32_0": "9260/0 Aneurysmal bone cyst", "0_0_1_32_1": "9261/3 Adamantinoma of long bones", "0_0_1_32_2": "9262/0 Ossifying fibroma", "0_0_1_33": "927-934 Odontogenic tumors", "0_0_1_33_0": "9270/0 Odontogenic tumor, benign", "0_0_1_33_1": "9270/1 Odontogenic tumor, NOS", "0_0_1_33_2": "9270/3 Odontogenic tumor, malignant", "0_0_1_33_3": "9271/0 Ameloblastic fibrodentinoma", "0_0_1_33_4": "9272/0 Cementoma, NOS", "0_0_1_33_5": "9273/0 Cementoblastoma, benign", "0_0_1_33_6": "9274/0 Cemento-ossifying fibroma", "0_0_1_33_7": "9275/0 Gigantiform cementoma", "0_0_1_33_8": "9280/0 Odontoma, NOS", "0_0_1_33_9": "9281/0 Compound odontoma", "0_0_1_33_10": "9282/0 Complex odontoma", "0_0_1_33_11": "9290/0 Ameloblastic fibro-odontoma", "0_0_1_33_12": "9290/3 Ameloblastic odontosarcoma", "0_0_1_33_13": "9300/0 Adenomatoid odontogenic tumor", "0_0_1_33_14": "9301/0 Calcifying odontogenic cyst", "0_0_1_33_15": "9302/0 Dentinogenic ghost cell tumor", "0_0_1_33_16": "9302/3 Ghost cell odontogenic carcinoma", "0_0_1_33_17": "9310/0 Ameloblastoma, NOS", "0_0_1_33_18": "9310/3 Ameloblastoma, metastasizing", "0_0_1_33_19": "9311/0 Odontoameloblastoma", "0_0_1_33_20": "9312/0 Squamous odontogenic tumor", "0_0_1_33_21": "9320/0 Odontogenic myxoma", "0_0_1_33_22": "9321/0 Odontogenic fibroma, NOS", "0_0_1_33_23": "9322/0 Peripheral odontogenic fibroma", "0_0_1_33_24": "9330/0 Ameloblastic fibroma", "0_0_1_33_25": "9330/3 Ameloblastic fibrosarcoma", "0_0_1_33_26": "9340/0 Calcifying epithelial odontogenic tumor", "0_0_1_33_27": "9341/3 Clear cell odontogenic carcinoma", "0_0_1_33_28": "9342/3 Odontogenic carcinosarcoma", "0_0_1_34": "935-937 Miscellaneous tumors", "0_0_1_34_0": "9350/1 Craniopharyngioma", "0_0_1_34_1": "9351/1 Craniopharyngioma, adamantinomatous", "0_0_1_34_2": "9352/1 Craniopharyngioma, papillary", "0_0_1_34_3": "9361/1 Pineocytoma", "0_0_1_34_4": "9362/3 Pineoblastoma", "0_0_1_34_5": "9363/0 Melanotic neuroectodermal tumor", "0_0_1_34_6": "9364/3 Ewing sarcoma", "0_0_1_34_7": "9365/3 Askin tumor", "0_0_1_34_8": "9370/0 Benign notochordal tumor", "0_0_1_34_9": "9370/3 Chordoma, NOS", "0_0_1_34_10": "9371/3 Chondroid chordoma", "0_0_1_34_11": "9372/3 Dedifferentiated chordoma", "0_0_1_34_12": "9373/0 Parachordoma", "0_0_1_35": "938-948 Gliomas", "0_0_1_35_0": "9380/3 Glioma, malignant", "0_0_1_35_1": "9381/3 Gliomatosis cerebri", "0_0_1_35_2": "9382/3 Oligoastrocytoma, NOS", "0_0_1_35_3": "9383/1 Subependymoma", "0_0_1_35_4": "9384/1 Subependymal giant cell astrocytoma", "0_0_1_35_5": "9385/3 Diffuse midline glioma, H3 K27M-mutant", "0_0_1_35_6": "9390/0 Choroid plexus papilloma, NOS", "0_0_1_35_7": "9390/1 Atypical choroid plexus papilloma", "0_0_1_35_8": "9390/3 Choroid plexus carcinoma", "0_0_1_35_9": "9391/1 Sellar ependymoma", "0_0_1_35_10": "9391/3 Ependymoma, NOS", "0_0_1_35_11": "9392/3 Ependymoma, anaplastic", "0_0_1_35_12": "9393/3 Papillary ependymoma", "0_0_1_35_13": "9394/1 Myxopapillary ependymoma", "0_0_1_35_14": "9395/3 Papillary tumor of the pineal region", "0_0_1_35_15": "9396/3 Ependymoma, RELA fusion-positive", "0_0_1_35_16": "9400/3 Astrocytoma, NOS", "0_0_1_35_17": "9401/3 Astrocytoma, anaplastic", "0_0_1_35_18": "9411/3 Gemistocytic astrocytoma, NOS", "0_0_1_35_19": "9412/1 Desmoplastic infantile astrocytoma", "0_0_1_35_20": "9413/0 Dysembryoplastic neuroepithelial tumor", "0_0_1_35_21": "9420/3 Fibrillary astrocytoma", "0_0_1_35_22": "9421/1 Pilocytic astrocytoma", "0_0_1_35_23": "9423/3 Polar spongioblastoma", "0_0_1_35_24": "9424/3 Pleomorphic xanthoastrocytoma", "0_0_1_35_25": "9425/3 Pilomyxoid astrocytoma", "0_0_1_35_26": "9431/1 Angiocentric glioma", "0_0_1_35_27": "9432/1 Pituicytoma", "0_0_1_35_28": "9440/3 Glioblastoma, NOS", "0_0_1_35_29": "9441/3 Giant cell glioblastoma", "0_0_1_35_30": "9442/1 Gliofibroma", "0_0_1_35_31": "9442/3 Gliosarcoma", "0_0_1_35_32": "9444/1 Chordoid glioma", "0_0_1_35_33": "9445/3 Glioblastoma, IDH-mutant", "0_0_1_35_34": "9450/3 Oligodendroglioma, NOS", "0_0_1_35_35": "9451/3 Oligodendroglioma, anaplastic, NOS", "0_0_1_35_36": "9470/3 Medulloblastoma, NOS", "0_0_1_35_37": "9471/3 Desmoplastic nodular medulloblastoma", "0_0_1_35_38": "9473/3 CNS embryonal tumor, NOS", "0_0_1_35_39": "9474/3 Large cell medulloblastoma", "0_0_1_35_40": "9475/3 Medullobloastoma, WNT-activated, NOS", "0_0_1_35_41": "9476/3 Medulloblastoma, SHH-activated and TP53-mutant", "0_0_1_35_42": "9477/3 Medulloblastoma, non-WNT/non-SHH", "0_0_1_35_43": "9478/3 Embryonal tumor with multilayered rosettes with C19MC alteration", "0_0_1_36": "949-952 Neuroepitheliomatous neoplasms", "0_0_1_36_0": "9490/0 Ganglioneuroma", "0_0_1_36_1": "9490/3 Ganglioneuroblastoma", "0_0_1_36_2": "9491/0 Ganglioneuromatosis", "0_0_1_36_3": "9492/0 Gangliocytoma, NOS", "0_0_1_36_4": "9493/0 Dysplastic gangliocytoma of cerebellum (Lhermitte-Duclos)", "0_0_1_36_5": "9500/3 Neuroblastoma, NOS", "0_0_1_36_6": "9501/0 Medulloepithelioma, benign", "0_0_1_36_7": "9501/3 Medulloepithelioma, NOS", "0_0_1_36_8": "9502/0 Teratoid medulloepithelioma, benign", "0_0_1_36_9": "9502/3 Teratoid medulloepithelioma, NOS", "0_0_1_36_10": "9503/3 Neuroepithelioma, NOS", "0_0_1_36_11": "9504/3 Spongioneuroblastoma", "0_0_1_36_12": "9505/1 Ganglioglioma, NOS", "0_0_1_36_13": "9505/3 Ganglioglioma, anaplastic", "0_0_1_36_14": "9506/1 Central neurocytoma", "0_0_1_36_15": "9507/0 Pacinian tumor", "0_0_1_36_16": "9508/3 Atypical teratoid/rhabdoid tumor", "0_0_1_36_17": "9509/1 Papillary glioneuronal tumor", "0_0_1_36_18": "9510/0 Retinocytoma", "0_0_1_36_19": "9510/3 Retinoblastoma, NOS", "0_0_1_36_20": "9511/3 Retinoblastoma, differentiated", "0_0_1_36_21": "9512/3 Retinoblastoma, undifferentiated", "0_0_1_36_22": "9513/3 Retinoblastoma, diffuse", "0_0_1_36_23": "9514/1 Retinoblastoma, spontaneously regressed", "0_0_1_36_24": "9520/3 Olfactory neurogenic tumor", "0_0_1_36_25": "9521/3 Olfactory neurocytoma", "0_0_1_36_26": "9522/3 Olfactory neuroblastoma", "0_0_1_36_27": "9523/3 Olfactory neuroepithelioma", "0_0_1_37": "953 Meningiomas", "0_0_1_37_0": "9530/0 Meningioma, NOS", "0_0_1_37_1": "9530/3 Meningioma, malignant", "0_0_1_37_2": "9531/0 Meningothelial meningioma", "0_0_1_37_3": "9532/0 Fibrous meningioma", "0_0_1_37_4": "9533/0 Psammomatous meningioma", "0_0_1_37_5": "9534/0 Angiomatous meningioma", "0_0_1_37_6": "9537/0 Transitional meningioma", "0_0_1_37_7": "9538/1 Clear cell meningioma", "0_0_1_37_8": "9538/3 Papillary meningioma", "0_0_1_37_9": "9539/1 Atypical meningioma", "0_0_1_37_10": "9539/3 Meningeal sarcomatosis", "0_0_1_38": "954-957 Nerve sheath tumors", "0_0_1_38_0": "9540/0 Neurofibroma, NOS", "0_0_1_38_1": "9540/3 Malignant peripheral nerve sheath tumor, NOS", "0_0_1_38_2": "9541/0 Melanotic neurofibroma", "0_0_1_38_3": "9542/3 Malignant peripheral nerve sheath tumor, epithelioid", "0_0_1_38_4": "9550/0 Plexiform neurofibroma", "0_0_1_38_5": "9560/0 Schwannoma, NOS", "0_0_1_38_6": "9560/1 Melanotic schwannoma", "0_0_1_38_7": "9561/3 Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation", "0_0_1_38_8": "9562/0 Nerve sheath myxoma", "0_0_1_38_9": "9563/0 Nerve sheath tumor, NOS", "0_0_1_38_10": "9570/0 Neuroma, NOS", "0_0_1_38_11": "9571/0 Perineurioma, NOS", "0_0_1_38_12": "9571/3 Perineurioma, malignant", "0_0_1_39": "958 Granular cell tumors and alveolar soft part sarcomas", "0_0_1_39_0": "9580/0 Granular cell tumor, NOS", "0_0_1_39_1": "9580/3 Granular cell tumor, malignant", "0_0_1_39_2": "9581/3 Alveolar soft part sarcoma", "0_0_1_39_3": "9582/0 Granular cell tumor of the sellar region", "0_0_1_40": "959-972 Hodgkin and non-Hodgkin lymphomas", "0_0_1_40_0": "9590/3 Malignant lymphoma, NOS", "0_0_1_40_1": "9591/1 Monoclonal B-cell lymphocytosis, NOS", "0_0_1_40_2": "9591/3 Malignant lymphoma, non-Hodgkin, NOS", "0_0_1_40_3": "9596/3 Composite Hodgkin and non-Hodgkin lymphoma", "0_0_1_40_4": "9597/3 Primary cutaneous follicle centre lymphoma", "0_0_1_40_5": "9650/3 Hodgkin lymphoma, NOS", "0_0_1_40_6": "9651/3 Hodgkin lymphoma, lymphocyte-rich", "0_0_1_40_7": "9652/3 Hodgkin lymphoma, mixed cellularity, NOS", "0_0_1_40_8": "9653/3 Hodgkin lymphoma, lymphocyte depletion, NOS", "0_0_1_40_9": "9654/3 Hodgkin lymphoma, lymphocyte depletion, diffuse fibrosis", "0_0_1_40_10": "9659/3 Hodgkin lymphoma, nodular lymphocyte predominant", "0_0_1_40_11": "9663/3 Hodgkin lymphoma, nodular sclerosis, NOS", "0_0_1_40_12": "9664/3 Hodgkin lymphoma, nodular sclerosis, cellular phase", "0_0_1_40_13": "9665/3 Hodgkin lymphoma, nodular sclerosis, grade 1", "0_0_1_40_14": "9667/3 Hodgkin lymphoma, nodular sclerosis, grade 2", "0_0_1_40_15": "9671/3 Lymphoplasmacytic lymphoma", "0_0_1_40_16": "9673/1 In situ mantle cell neoplasia", "0_0_1_40_17": "9673/3 Mantle cell lymphoma", "0_0_1_40_18": "9678/3 Primary effusion lymphoma", "0_0_1_40_19": "9679/3 Mediastinal large B-cell lymphoma", "0_0_1_40_20": "9680/1 EBV positive mucocutaneous ulcer", "0_0_1_40_21": "9680/3 Diffuse large B-cell lymphoma, NOS", "0_0_1_40_22": "9684/3 Malignant lymphoma, large B-cell, diffuse, immunoblastic, NOS", "0_0_1_40_23": "9687/3 Burkitt lymphoma, NOS", "0_0_1_40_24": "9688/3 T-cell/histiocyte rich large B-cell lymphoma", "0_0_1_40_25": "9689/3 Splenic marginal zone B-cell lymphoma", "0_0_1_40_26": "9690/3 Follicular lymphoma, NOS", "0_0_1_40_27": "9691/3 Follicular lymphoma, grade 2", "0_0_1_40_28": "9695/1 In situ follicular neoplasia", "0_0_1_40_29": "9695/3 Follicular lymphoma, grade 1", "0_0_1_40_30": "9698/3 Follicular lymphoma, grade 3", "0_0_1_40_31": "9699/3 Marginal zone B-cell lymphoma, NOS", "0_0_1_40_32": "9700/3 Mycosis fungoides", "0_0_1_40_33": "9701/3 Sezary syndrome", "0_0_1_40_34": "9702/1 Indolent T-cell lymphoproliferative disorder of the gastrointestinal tract", "0_0_1_40_35": "9702/3 Mature T-cell lymphoma, NOS", "0_0_1_40_36": "9705/3 Angioimmunoblastic T-cell lymphoma", "0_0_1_40_37": "9708/3 Subcutaneous panniculitis-like T-cell lymphoma", "0_0_1_40_38": "9709/1 Primary cutaneous CD4-positive small/medium T-cell lymphoproliferative disorder", "0_0_1_40_39": "9709/3 Cutaneous T-cell lymphoma, NOS", "0_0_1_40_40": "9712/3 Intravascular large B-cell lymphoma", "0_0_1_40_41": "9714/3 Anaplastic large cell lymphoma, T-cell and Null-cell type", "0_0_1_40_42": "9715/3 Anaplastic large cell lymphoma, ALK negative", "0_0_1_40_43": "9716/3 Hepatosplenic T-cell lymphoma", "0_0_1_40_44": "9717/3 Intestinal T-cell lymphoma", "0_0_1_40_45": "9718/1 Primary cutaneous CD30+T-cell lymphoproliferative disorder", "0_0_1_40_46": "9718/3 Primary cutaneous anaplastic large cell lymphoma", "0_0_1_40_47": "9719/3 NK/T-cell lymphoma, nasal and nasal type", "0_0_1_40_48": "9724/3 Systemic EBV positive T-cell lymphoproliferative disease of childhood", "0_0_1_40_49": "9725/1 Hydroa vacciniforme-like lymphoproliferative disorder", "0_0_1_40_50": "9726/3 Primary cutaneous gamma-delta T-cell lymphoma", "0_0_1_40_51": "9727/3 Precursor cell lymphoblastic lymphoma, NOS", "0_0_1_41": "973 Plasma cell neoplasms", "0_0_1_41_0": "9731/3 Plasmacytoma, NOS", "0_0_1_41_1": "9732/3 Plasma cell myeloma", "0_0_1_41_2": "9733/3 Plasma cell leukemia", "0_0_1_41_3": "9734/3 Plasmacytoma, extramedullary", "0_0_1_41_4": "9735/3 Plasmablastic lymphoma", "0_0_1_41_5": "9737/3 ALK positive large B-cell lymphoma", "0_0_1_41_6": "9738/3 HHV8-positive diffuse large B-cell lymphoma", "0_0_1_42": "974 Mast cell neoplasms", "0_0_1_42_0": "9740/1 Mastocytoma, NOS", "0_0_1_42_1": "9740/3 Mast cell sarcoma", "0_0_1_42_2": "9741/1 Indolent systemic mastocytosis", "0_0_1_42_3": "9741/3 Malignant mastocytosis", "0_0_1_42_4": "9742/3 Mast cell leukemia", "0_0_1_42_5": "9749/3 Erdheim-Chester disease", "0_0_1_43": "975 Neoplasms of histiocytes and accessory lymphoid cells", "0_0_1_43_0": "9750/3 Malignant histiocytosis", "0_0_1_43_1": "9751/1 Langerhans cell histiocytosis, NOS", "0_0_1_43_2": "9751/3 Langerhans cell histiocytosis, disseminated", "0_0_1_43_3": "9755/3 Histiocytic sarcoma", "0_0_1_43_4": "9756/3 Langerhans cell sarcoma", "0_0_1_43_5": "9757/3 Interdigitating dendritic cell sarcoma", "0_0_1_43_6": "9758/3 Follicular dendritic cell sarcoma", "0_0_1_43_7": "9759/3 Fibroblastic reticular cell tumor", "0_0_1_44": "976 Immunoproliferative diseases", "0_0_1_44_0": "9760/3 Immunoproliferative disease, NOS", "0_0_1_44_1": "9761/1 IgM monoclonal gammopathy of undetermined significance", "0_0_1_44_2": "9761/3 Waldenstrom macroglobulinemia", "0_0_1_44_3": "9762/3 Heavy chain disease, NOS", "0_0_1_44_4": "9764/3 Immunoproliferative small intestinal disease", "0_0_1_44_5": "9765/1 Monoclonal gammopathy of undetermined significance, NOS", "0_0_1_44_6": "9766/1 Angiocentric immunoproliferative lesion", "0_0_1_44_7": "9766/3 Lymphomatoid granulomatosis, grade 3", "0_0_1_44_8": "9767/1 Angioimmunoblastic lymphadenopathy (AIL)", "0_0_1_44_9": "9768/1 T-gamma lymphoproliferative disease", "0_0_1_44_10": "9769/1 Immunoglobulin deposition disease", "0_0_1_45": "980-994 Leukemias", "0_0_1_45_0": "9800/3 Leukemia, NOS", "0_0_1_45_1": "9801/3 Acute leukemia, NOS", "0_0_1_45_2": "9805/3 Acute biphenotypic leukemia", "0_0_1_45_3": "9806/3 Mixed phenotype acute leukemia with t(9;22)(q34;q11.2); BCR-ABL1", "0_0_1_45_4": "9807/3 Mixed phenotype acute leukemia with t(v;11q23); MLL rearranged", "0_0_1_45_5": "9808/3 Mixed phenotype acute leukemia, B/myeloid, NOS", "0_0_1_45_6": "9809/3 Mixed phenotype acute leukemia, T/myeloid, NOS", "0_0_1_45_7": "9811/3 B lymphoblastic leukemia/lymphoma, NOS", "0_0_1_45_8": "9812/3 B lymphoblastic leukemia/lymphoma with t(9;22)(q34;q11.2); BCR-ABL1", "0_0_1_45_9": "9813/3 B lymphoblastic leukemia/lymphoma with t(v;11q23); MLL rearranged", "0_0_1_45_10": "9814/3 B lymphoblastic leukemia/lymphoma with t(12;21)(p13;q22); TEL-AML1(ETV6-RUNX1)", "0_0_1_45_11": "9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy", "0_0_1_45_12": "9816/3 B lymphoblastic leukemia/lymphoma with hypodiploidy(Hypodiploid ALL)", "0_0_1_45_13": "9817/3 B lymphoblastic leukemia/lymphoma with t(5;14)(q31;q32); IL3-IGH", "0_0_1_45_14": "9818/3 B lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3); E2A-PBX1(TCF3-PBX1)", "0_0_1_45_15": "9819/3 B lymphoblastic leukemia/lymphoma, BCR-ABL1-like", "0_0_1_45_16": "9820/3 Lymphoid leukemia, NOS", "0_0_1_45_17": "9823/1 Monoclonal B-cell lymphocytosis, CLL type", "0_0_1_45_18": "9823/3 B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma", "0_0_1_45_19": "9827/3 Adult T-cell leukemia/lymphoma (HTLV-1 positive)", "0_0_1_45_20": "9831/3 T-cell large granular lymphocytic leukemia", "0_0_1_45_21": "9832/3 Prolymphocytic leukemia, NOS", "0_0_1_45_22": "9833/3 Prolymphocytic leukemia, B-cell type", "0_0_1_45_23": "9834/3 Prolymphocytic leukemia, T-cell type", "0_0_1_45_24": "9835/3 Precursor cell lymphoblastic leukemia, NOS", "0_0_1_45_25": "9837/3 Precursor T-cell lymphoblastic leukemia", "0_0_1_45_26": "9840/3 Acute erythroid leukemia", "0_0_1_45_27": "9860/3 Myeloid leukemia, NOS", "0_0_1_45_28": "9861/3 Acute myeloid leukemia, NOS", "0_0_1_45_29": "9863/3 Chronic myeloid leukemia, NOS", "0_0_1_45_30": "9865/3 Acute myeloid leukemia with t(6;9)(p23;q34); DEK-NUP214", "0_0_1_45_31": "9866/3 Acute promyelocytic leukemia, t(15;17)(q22;q11-12)", "0_0_1_45_32": "9867/3 Acute myelomonocytic leukemia, NOS", "0_0_1_45_33": "9869/3 Acute myeloid leukemia with inv(3)(q21;q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1", "0_0_1_45_34": "9870/3 Acute basophilic leukemia", "0_0_1_45_35": "9871/3 Acute myeloid leukemia with abnormal marrow eosinophils", "0_0_1_45_36": "9872/3 Acute myeloid leukemia, minimal differentiation", "0_0_1_45_37": "9873/3 Acute myeloid leukemia without maturation", "0_0_1_45_38": "9874/3 Acute myeloid leukemia with maturation", "0_0_1_45_39": "9875/3 Chronic myelogenous leukemia, BCR/ABL positive", "0_0_1_45_40": "9876/3 Atypical chronic myeloid leukemia, BCR/ABL negative", "0_0_1_45_41": "9877/3 Acute myeloid leukemia with mutated NPM1", "0_0_1_45_42": "9878/3 Acute myeloid leukemia with biallelic mutation of CEBPA", "0_0_1_45_43": "9879/3 Acute myeloid leukemia with mutated RUNX1", "0_0_1_45_44": "9891/3 Acute monocytic leukemia", "0_0_1_45_45": "9895/3 Acute myeloid leukemia with myelodysplasia-related changes", "0_0_1_45_46": "9896/3 Acute myeloid leukemia, t(8;21)(q22;q22)", "0_0_1_45_47": "9897/3 Acute myeloid leukemia, 11q23 abnormalities", "0_0_1_45_48": "9898/1 Transient abnormal myelopoiesis", "0_0_1_45_49": "9898/3 Myeloid leukemia associated with Down syndrome", "0_0_1_45_50": "9910/3 Acute megakaryoblastic leukemia", "0_0_1_45_51": "9911/3 Acute myeloid leukemia (megakaryoblastic) with t(1;22)(p13;q13); RBM15-MKL1", "0_0_1_45_52": "9912/3 Acute myleoid leukemia with BCR-ABL1", "0_0_1_45_53": "9920/3 Therapy-related myeloid neoplasm", "0_0_1_45_54": "9930/3 Myeloid sarcoma", "0_0_1_45_55": "9931/3 Acute panmyelosis with myelofibrosis", "0_0_1_45_56": "9940/3 Hairy cell leukemia, NOS", "0_0_1_45_57": "9945/3 Chronic myelomonocytic leukemia, NOS", "0_0_1_45_58": "9946/3 Juvenile myelomonocytic leukemia, NOS", "0_0_1_45_59": "9948/3 Aggressive NK-cell leukemia", "0_0_1_46": "995-996 Myeloproliferative neoplasms", "0_0_1_46_0": "9950/3 Polycythemia vera", "0_0_1_46_1": "9960/3 Myeloproliferative neoplasm, NOS", "0_0_1_46_2": "9961/3 Primary myelofibrosis", "0_0_1_46_3": "9962/3 Essential thrombocythemia", "0_0_1_46_4": "9963/3 Chronic neutrophilic leukemia", "0_0_1_46_5": "9964/3 Chronic eosinophilic leukemia", "0_0_1_46_6": "9965/3 Myeloid or lymphoid neoplasm with PDGFRA rearrangement", "0_0_1_46_7": "9966/3 Myeloid neoplasm with PDGFRB rearrangement", "0_0_1_46_8": "9967/3 Myeloid or lymphoid neoplasm with FGFR1 abnormalities", "0_0_1_46_9": "9968/3 Myeloid or lymphoid neoplasm with PCM1-JAK2", "0_0_1_47": "997 Other hematological neoplasms", "0_0_1_47_0": "9970/1 Lymphoproliferative disorder, NOS", "0_0_1_47_1": "9971/1 Post transplant lymphoproliferative disorder, NOS", "0_0_1_47_2": "9975/3 Myeloproliferative neoplasm, unclassifiable", "0_0_1_48": "998-999 Myelodysplastic syndromes", "0_0_1_48_0": "9980/3 Myelodysplastic syndrome with single lineage dysplasia", "0_0_1_48_1": "9982/3 Myelodysplastic syndrome with ring sideroblasts and single lineage dysplasia", "0_0_1_48_2": "9983/3 Myelodysplastic syndrome with excess blasts", "0_0_1_48_3": "9985/3 Myelodysplastic syndrome with multilineage dysplasia", "0_0_1_48_4": "9986/3 Myelodysplastic syndrome with isolated del (5q)", "0_0_1_48_5": "9987/3 Therapy-related myelodysplastic syndrome, NOS", "0_0_1_48_6": "9989/3 Myelodysplastic syndrome, NOS", "0_0_1_48_7": "9993/3 Myelodysplastic syndrome with ring sideroblasts and multilineage dysplasia", "0_0_2": "crukTerms", "0_0_2_0": "All", "0_0_2_1": "Acute lymphoblastic leukaemia (ALL)", "0_0_2_2": "Acute lymphoblastic leukaemia (ALL) in children", "0_0_2_3": "Acute myeloid leukaemia (AML)", "0_0_2_4": "Adrenal gland tumours", "0_0_2_5": "Ampullary cancer", "0_0_2_6": "Anal cancer", "0_0_2_7": "Basal cell skin cancer", "0_0_2_8": "Bile duct cancer", "0_0_2_9": "Bladder cancer", "0_0_2_10": "Blood cancers", "0_0_2_11": "Bone cancer", "0_0_2_12": "Bowel cancer", "0_0_2_13": "Brain tumours", "0_0_2_14": "Brain tumours in children", "0_0_2_15": "Breast cancer", "0_0_2_16": "Breast cancer in men", "0_0_2_17": "Cancer of unknown primary (CUP)", "0_0_2_18": "Cancer spread to bone", "0_0_2_19": "Cancer spread to brain", "0_0_2_20": "Cancer spread to liver", "0_0_2_21": "Cancer spread to lung", "0_0_2_22": "Carcinoid", "0_0_2_23": "Cervical cancer", "0_0_2_24": "Children's cancers", "0_0_2_25": "Cholangiocarcinoma", "0_0_2_26": "Chronic lymphocytic leukaemia (CLL)", "0_0_2_27": "Chronic myeloid leukaemia (CML)", "0_0_2_28": "Chronic myelomonocytic leukaemia (CMML)", "0_0_2_29": "Colorectal cancer", "0_0_2_30": "Ear cancer", "0_0_2_31": "Endometrial cancer", "0_0_2_32": "Essential Thrombocythaemia (ET)", "0_0_2_33": "Eye cancer", "0_0_2_34": "Follicular dendritic cell sarcoma", "0_0_2_35": "Gallbladder cancer", "0_0_2_36": "Gastric cancer", "0_0_2_37": "Gastro oesophageal junction cancers", "0_0_2_38": "Germ cell tumours", "0_0_2_39": "Gestational trophoblastic disease (GTD)", "0_0_2_40": "Hairy cell leukaemia", "0_0_2_41": "Head and neck cancer", "0_0_2_42": "Hodgkin lymphoma", "0_0_2_43": "Invasive mole and choriocarcinomas", "0_0_2_44": "Juvenile myelomonocytic leukaemia (JMML)", "0_0_2_45": "Kaposi's sarcoma", "0_0_2_46": "Kidney cancer", "0_0_2_47": "Large bowel and rectal neuroendocrine tumours", "0_0_2_48": "Laryngeal cancer", "0_0_2_49": "Leukaemia", "0_0_2_50": "Liver cancer", "0_0_2_51": "Lung cancer", "0_0_2_52": "Lung neuroendocrine tumours (NETs)", "0_0_2_53": "Lymphoma", "0_0_2_54": "Malignant schwannoma", "0_0_2_55": "Mediastinal germ cell tumours", "0_0_2_56": "Melanoma skin cancer", "0_0_2_57": "Men's cancer", "0_0_2_58": "Merkel cell skin cancer", "0_0_2_59": "Mesothelioma", "0_0_2_60": "Mouth and oropharyngeal cancer", "0_0_2_61": "Myelodysplastic syndromes (MDS)", "0_0_2_62": "Myelofibrosis", "0_0_2_63": "Myeloma", "0_0_2_64": "Myeloproliferative neoplasms", "0_0_2_65": "Nasal and paranasal sinus cancer", "0_0_2_66": "Nasopharyngeal cancer", "0_0_2_67": "Neuroblastoma", "0_0_2_68": "Neuroendocrine tumours", "0_0_2_69": "Neuroendocrine tumours of the pancreas", "0_0_2_70": "Non-Hodgkin lymphoma", "0_0_2_71": "Non-Hodgkin lymphoma in children", "0_0_2_72": "Oesophageal cancer", "0_0_2_73": "Other conditions", "0_0_2_74": "Ovarian cancer", "0_0_2_75": "Pancreatic cancer", "0_0_2_76": "Penile cancer", "0_0_2_77": "Persistent trophoblastic disease and choriocarcinoma", "0_0_2_78": "Phaeochromocytoma", "0_0_2_79": "Placental site trophoblastic tumour and epithelioid trophoblastic tumour", "0_0_2_80": "Polycythaemia vera (PV)", "0_0_2_81": "Prostate cancer", "0_0_2_82": "Pseudomyxoma peritonei", "0_0_2_83": "Rare cancer", "0_0_2_84": "Rectal cancer", "0_0_2_85": "Retinoblastoma", "0_0_2_86": "Salivary gland cancer", "0_0_2_87": "Secondary cancer", "0_0_2_88": "Signet cell cancer", "0_0_2_89": "Skin cancer (including basal cell and squamous cell skin cancers)", "0_0_2_90": "Small bowel cancer", "0_0_2_91": "Small bowel neuroendocrine tumours (NETs)", "0_0_2_92": "Soft tissue sarcoma", "0_0_2_93": "Spinal cord tumours", "0_0_2_94": "Squamous cell skin cancer", "0_0_2_95": "Stomach cancer", "0_0_2_96": "Stomach neuroendocrine tumours (NETs)", "0_0_2_97": "Testicular cancer", "0_0_2_98": "Thymus gland tumours", "0_0_2_99": "Thyroid cancer", "0_0_2_100": "Tongue cancer", "0_0_2_101": "Tonsil cancer", "0_0_2_102": "Tumours of the adrenal gland", "0_0_2_103": "Unknown primary cancer", "0_0_2_104": "Upper urinary tract urothelial cancer", "0_0_2_105": "Uterine cancer", "0_0_2_106": "Vaginal cancer", "0_0_2_107": "Vulval cancer", "0_0_2_108": "Wilms tumour", "0_0_2_109": "Womb cancer", "0_0_2_110": "Women's cancers (gynaecological cancer)", "0_0_4": "tcga", "0_0_4_0": "ACC (Adrenocortical carcinoma)", "0_0_4_1": "BLCA (Bladder Urothelial Carcinoma)", "0_0_4_2": "BRCA (Breast invasive carcinoma)", "0_0_4_3": "CESC (Cervical squamous cell carcinoma and endocervical adenocarcinoma)", "0_0_4_4": "CHOL (Cholangiocarcinoma)", "0_0_4_5": "CNTL (Controls)", "0_0_4_6": "COAD (Colon adenocarcinoma)", "0_0_4_7": "DLBC (Lymphoid Neoplasm Diffuse Large B-cell Lymphoma)", "0_0_4_8": "ESCA (Esophageal carcinoma)", "0_0_4_9": "FPPP (FFPE Pilot Phase II)", "0_0_4_10": "GBM (Glioblastoma multiforme)", "0_0_4_11": "HNSC (Head and Neck squamous cell carcinoma)", "0_0_4_12": "KICH (Kidney Chromophobe)", "0_0_4_13": "KIRC (Kidney renal clear cell carcinoma)", "0_0_4_14": "KIRP (Kidney renal papillary cell carcinoma)", "0_0_4_15": "LAML (Acute Myeloid Leukemia)", "0_0_4_16": "LCML (Chronic Myelogenous Leukemia)", "0_0_4_17": "LGG (Brain Lower Grade Glioma)", "0_0_4_18": "LIHC (Liver hepatocellular carcinoma)", "0_0_4_19": "LUAD (Lung adenocarcinoma)", "0_0_4_20": "LUSC (Lung squamous cell carcinoma)", "0_0_4_21": "MESO (Mesothelioma)", "0_0_4_22": "MISC (Miscellaneous)", "0_0_4_23": "OV (Ovarian serous cystadenocarcinoma)", "0_0_4_24": "PAAD (Pancreatic adenocarcinoma)", "0_0_4_25": "PCPG (Pheochromocytoma and Paraganglioma)", "0_0_4_26": "PRAD (Prostate adenocarcinoma)", "0_0_4_27": "READ (Rectum adenocarcinoma)", "0_0_4_28": "SARC (Sarcoma)", "0_0_4_29": "SKCM (Skin Cutaneous Melanoma)", "0_0_4_30": "STAD (Stomach adenocarcinoma)", "0_0_4_31": "TGCT (Testicular Germ Cell Tumors)", "0_0_4_32": "THCA (Thyroid carcinoma)", "0_0_4_33": "THYM (Thymoma)", "0_0_4_34": "UCEC (Uterine Corpus Endometrial Carcinoma)", "0_0_4_35": "UCS (Uterine Carcinosarcoma)", "0_0_4_36": "UVM (Uveal Melanoma)", "0_1": "accessType", "0_1_0": "Restriction level", "0_1_0_0": "Direct Access", "0_1_0_1": "Data Access Committee", "0_1_0_2": "Limited to Federated Learning", "0_1_0_3": "Not available", "0_1_1": "Persons", "0_1_1_0": "Collaboration only", "0_1_1_1": "Academic only", "0_1_1_2": "Not for profit", "0_1_1_3": "Commercial", "0_2": "dataType", "0_2_0": "Biobank Samples", "0_2_0_0": "Material type", "0_2_0_0_0": "Bloods ", "0_2_0_0_1": "Cells - eg cell lines", "0_2_0_0_2": "Genetic material", "0_2_0_0_3": "Other Fluids - eg urine", "0_2_0_0_4": "Organoids", "0_2_0_0_5": "Tissues - eg Bone marrow aspirate", "0_2_0_0_6": "Other - eg swab", "0_2_0_1": "State", "0_2_0_1_0": "Malignant", "0_2_0_1_1": "Normal", "0_2_0_1_2": "Pre-cancerous", "0_2_1": "In Vitro Study", "0_2_1_0": "Model", "0_2_1_0_0": "Organ on a Chip", "0_2_1_0_1": "3D organoid (including on a chip)", "0_2_1_0_2": "Organ slice", "0_2_1_1": "Cell Source", "0_2_1_1_0": "Immortalised cell-line", "0_2_1_1_1": "Patient derived", "0_2_1_1_2": "Model Organism derived", "0_2_1_2": "Treatment", "0_2_1_2_0": "Cell and cell-derived treatment", "0_2_1_2_1": "Gene knock-down", "0_2_1_2_2": "Medication", "0_2_1_2_3": "Radiation", "0_2_2": "Model Organism", "0_2_2_0": "Organism", "0_2_2_0_0": "Chicken", "0_2_2_0_1": "Dog", "0_2_2_0_2": "Fruit fly", "0_2_2_0_3": "Mouse", "0_2_2_0_4": "Rabbit", "0_2_2_0_5": "Rat", "0_2_2_0_6": "Saccharomyces cerevisiae", "0_2_2_0_7": "Schizosaccharomyces pombe", "0_2_2_1": "Organism preparation", "0_2_2_1_0": "Genetically engineered", "0_2_2_1_1": "Immuno-compromised", "0_2_2_1_2": "Patient-Derived xenograft", "0_2_2_1_3": "Syngeneic", "0_2_2_2": "Biopsy & Lab Results", "0_2_2_2_0": "Biomarkers", "0_2_2_2_1": "Flow Cytometry", "0_2_2_2_2": "Immunohistochemistry", "0_2_2_3": "Longitudinal Follow up", "0_2_2_3_0": "Behavioural data", "0_2_2_3_1": "Clinical observations", "0_2_2_3_2": "Response outcomes", "0_2_2_3_3": "Side effects", "0_2_2_3_4": "Survival data", "0_2_2_4": "Treatments", "0_2_2_4_0": "Medication", "0_2_2_4_1": "Cell and cell-derived treatments", "0_2_2_4_2": "Micro-biome alterations", "0_2_2_4_3": "Organ resection and other ablations", "0_2_2_4_4": "Radiotherapies", "0_2_3": "Patient study", "0_2_3_0": "Background", "0_2_3_0_0": "Child and Young Person", "0_2_3_0_1": "Seniors", "0_2_3_0_2": "Demographic", "0_2_3_0_3": "Family history", "0_2_3_0_4": "Lifestyle", "0_2_3_0_5": "Quality of life (eg Education and/or employment)", "0_2_3_1": "Biopsy Reports and Lab Results", "0_2_3_1_0": "Biomarkers", "0_2_3_1_1": "Complete blood count", "0_2_3_1_2": "H&E-stained tissue microarrays", "0_2_3_1_3": "Immunohistochemistry", "0_2_3_1_4": "Kidney function tests", "0_2_3_1_5": "Liver function tests", "0_2_3_1_6": "Other bodily fluid analyses", "0_2_3_1_7": "Tumour details", "0_2_3_1_8": "Urine tests", "0_2_3_2": "Longitudinal Follow up", "0_2_3_2_0": "Patient-Reported Outcomes", "0_2_3_2_1": "Response outcomes", "0_2_3_2_2": "Side effects", "0_2_3_2_3": "Survival data", "0_2_3_3": "Treatments", "0_2_3_3_0": "Medication", "0_2_3_3_1": "Organ resection and other ablations", "0_2_3_3_2": "Radiotherapies", "0_2_3_4": "Clinical Trial", "0_2_3_4_0": "Phase 0", "0_2_3_4_1": "Phase 1", "0_2_3_4_2": "Phase 2", "0_2_3_4_3": "Phase 3", "0_2_3_4_4": "Phase 4", "0_2_4": "Techniques", "0_2_4_0": "Computational Model", "0_2_4_1": "Crystallography", "0_2_4_2": "Imaging Data", "0_2_4_2_0": "Bioluminescence Imaging", "0_2_4_2_1": "Fluorescence Imaging", "0_2_4_2_2": "Magnetic Resonance Imaging", "0_2_4_2_3": "Medical photography", "0_2_4_2_4": "Microscopy", "0_2_4_2_5": "Nuclear medicine imaging", "0_2_4_2_6": "Radiographic imaging", "0_2_4_2_7": "Ultrasonography", "0_2_4_3": "Mechanobiology", "0_2_4_4": "Multi-omic Data", "0_2_4_4_0": "Biological molecules (eg DNA)", "0_2_4_4_0_0": "Epigenomics", "0_2_4_4_0_1": "Genomics", "0_2_4_4_0_1_0": "SNVs", "0_2_4_4_0_1_1": "Indels", "0_2_4_4_0_1_2": "CNVs", "0_2_4_4_0_1_3": "Fusion Genes", "0_2_4_4_0_2": "Metabolomics", "0_2_4_4_0_3": "Metagenomics", "0_2_4_4_0_4": "Proteomics", "0_2_4_4_0_5": "Transcriptomics", "0_2_4_4_1": "Source", "0_2_4_4_1_0": "Control", "0_2_4_4_1_1": "Liquid Biopsy", "0_2_4_4_1_2": "Other", "0_2_4_4_1_3": "Tumour", "0_2_4_4_2": "Spatial resolution", "0_2_4_4_2_0": "bulk", "0_2_4_4_2_1": "single cell", "0_2_4_4_2_2": "spatial", "0_2_4_5": "Nanomaterials", "0_2_4_6": "Spectroscopy"}